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ABSTRACT 
WNT2 SIGNALING IN LUNG DEVELOPMENT 
 
Author: Ashley M. Goss 
Supervisor: Edward E. Morrisey, Ph.D 
 
Development of the vertebrate lung is a complex process involving the input of signaling 
pathways to coordinate the specification and differentiation of multiple cell types. The 
Wnt signaling pathway plays a critical role in the development of many vertebrate tissue 
types, including the lung. However, the functions of individual Wnt ligands during the 
specification and development of respiratory lineages have not been fully addressed. In 
this dissertation, I combine mouse genetic models and ex vivo tissue culture assays to 
determine the function of Wnt2 signaling in lung development. These studies reveal 
critical roles for Wnt2 signaling during the specification of lung progenitors in the 
foregut endoderm, and during airway smooth muscle development. These findings 
provide new insight into the position and contributions of Wnt signaling within the 
hierarchy of signaling pathways governing lung morphogenesis. 
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Chapter 1: Introduction 
 
Summary 
The evolutionarily conserved Wnt signaling pathway regulates numerous 
processes during embryonic development, including patterning of the foregut endoderm 
from which the lung arises. Genetic studies in the mouse highlight the contributions of 
Wnt signaling to the specification and morphogenesis of not only the lung, but also other 
foregut-derived organs, such as the liver and pancreas. However, there is little data 
describing the molecular mechanisms and targets of Wnt signaling in the developing 
lung. This introductory chapter will summarize the current understanding of Wnt 
signaling in mouse foregut development, with emphasis placed on identifying critical 
questions concerning the function of Wnt signaling in lung development. 
 
The role of signaling pathways in lung development and disease 
The adult lung is an incredibly complex organ comprised of more than forty 
different cell types with cells serving both respiratory and nonrespiratory functions
1
. The 
primary function of the lung is to enable gas exchange, and the principle components 
contributing to this function are a network of branched airway tubules juxtaposed with a 
similarly branched vascular system. Furthermore, specialized cell types within the airway 
epithelium carry out additional functions, including surfactant secretion, mucus 
clearance, fluid transport, and immune surveillance and response
2-6
.  
Not surprisingly, defects in the signaling pathways that guide the growth and 
differentiation of these lung cell types can present serious risks for human development. 
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Mutations in several signaling pathway components are implicated in a broad spectrum of 
human birth defects referred to as esophageal atresia (EA) and tracheal esophageal fistula 
(TEF)
7-10
. Moreover, abnormal expression of developmental signaling pathways in the 
adult lung is correlated to certain diseases including fibrosis
11
, emphysema
12, 13
, and 
cancer
14-16
.  
Wnt proteins are critical intercellular transducing signals expressed during lung 
development that are often aberrantly expressed in lung diseases. Several Wnt ligands 
and components of the Wnt signaling pathway are mutated in many types of lung 
cancers
17-19
. Direct evidence for Wnt signaling and cancer incidence is demonstrated by 
dominant activation of Wnt signaling in the adult mouse lung epithelium, which results in 
higher incidence of pulmonary adenomas
20
. Activated Wnt signaling has also been 
identified in fibroproliferative diseases such as asthma, pulmonary arterial hypertension 
(PAH), and chronic obstructive pulmonary disease (COPD)
21, 22
. Altogether, the 
emerging data point to a contributing role for Wnt signaling in lung disease. A more 
thorough understanding of the mechanisms of Wnt signaling in lung development will 
help to inform therapeutic strategies and clinical care for both congenital and adult lung 
diseased states. 
 
Overview of the Wnt signaling pathway 
Wnt proteins are cysteine-rich secreted glycoproteins that signal through at least 
three known pathways (outlined in Figure 1.1). Pathway activation involves binding of 
Wnt ligands to a receptor complex comprised of the Frizzled (Fzd) family of seven-pass 
transmembrane receptors and members of the family of lipoprotein receptor related 5/6 
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proteins (Lrp5/6). Currently, 19 Wnt proteins, 10 Fzd receptors, and two Lrp co-receptors 
have been identified in mammals
23
. Adding further complexity to the pathway, studies 
have demonstrated that individual Wnt proteins can activate several pathways in a cell-
type and context-dependent manner
24-26
. Therefore, the particular pathway a Wnt ligand 
signals through will depend on specific Wnt-Fzd combinations and the presence or levels 
of intracellular factors that can prevent signaling of one pathway over another
27, 28
. 
Wnt proteins mediate many of their effects through the canonical Wnt signaling 
pathway
29
 (Figure 1.1). Activation of the canonical pathway begins with Wnt ligand 
binding to the Fzd-Lrp5/6 co-receptor complex and activation of the intracellular effector 
protein Disheveled (Dvl), which subsequently inactivates a complex of proteins including 
the constitutively active serine-threonine kinase glycogen synthase kinase 3! (Gsk3!), 
the scaffolding proteins Axin, and adenomatosis polyposis coli (APC). In the absence of 
Wnt stimulation, this complex phosphorylates !-catenin, thereby targeting it for 
proteosomal degradation. Upon Wnt pathway activation, inhibition of this !-catenin 
degradation complex allows !-catenin to accumulate at high levels and translocate into 
the nucleus where it complexes with the LEF/TCF family of transcription factors to 
activate target gene expression
28
. 
Some Wnt ligands also signal through !-catenin independent pathways (Figure 
1.1). The best characterized of these non-canonical Wnt pathways are the Ca
2+
/protein 
kinase C (PKC) and RhoA/ Jun-N-Terminal Kinase (JNK) pathways
30
. In Ca
2+
/PKC 
signaling, Wnt binding activates a G-protein dependent activity of Fzd receptors that in 
turn activates intracellular calcium signaling and calcium dependent protein kinases, 
including PKC and calmodulin-dependent protein kinase II (CaMKII)
31, 32
. In RhoA/JNK 
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signaling, Dvl activates the Rho family of GTPases (RhoA, Rac, and Cdc42) and their 
downstream effectors including Rho Associated Kinase (ROK) and JNK
33
. Although 
these pathways mediate the majority of !-catenin independent Wnt signaling, it remains 
unclear whether these pathways are truly distinct from one another. Furthermore, recent 
studies have identified increasing examples of interplay between canonical and non-
canonical pathways, as activated non-canonical signaling often attenuates canonical 
signaling
34, 35
. This is suggestive of a broader Wnt signaling network characterized by 
distinct combinations of effectors being activated for different environmental contexts 
and cell-types. 
The Wnt ligands and their downstream signaling pathways are evolutionarily 
conserved mediators of numerous developmental processes including cell fate 
specification, proliferation, migration, and adhesion
36-40
. A significant amount of data 
describing the role of Wnts in vertebrate development exists in the literature, however 
more evidence is needed to fully understand the contributions of specific Wnt ligands and 
their associated downstream signaling mechanisms to vertebrate development and 
organogenesis. 
 
Vertebrate development and organogenesis 
In the early vertebrate embryo, cells of the totipotent epiblast segregate into three 
embryonic lineages or germ layers — the mesoderm, which forms muscle, blood, and 
bone; the ectoderm, which yields the skin and nervous system; and the endoderm, which 
gives rise to the lining of the respiratory and digestive tracts. Segregation of these 
primordial lineages occurs during gastrulation (E6.0-E7.5 in the mouse), whereby the 
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totipotent cells of the epiblast divide, rearrange, and involute to set up the vertebrate body 
plan
41
. At the end of gastrulation, the early endoderm consists of a sheet of cells 
extending along the anterior-posterior axis (A-P) of the embryo
42
. Over a twenty-four 
hour period, morphogenetic movements transform the endoderm sheet into the primitive 
gut tube, from which endoderm-derived organs will bud
43-45
 (Figure 1.2A). The 
endoderm of the primitive gut tube is divided into three broad sections-the foregut, which 
is the most anterior portion; the midgut; and the hindgut. In the mouse, the foregut 
endoderm gives rise to organs including the thyroid, lungs, liver, ventral pancreas, and 
stomach. The midgut and hindgut give rise to the stomach, dorsal pancreas, and 
intestines
46
 (Figure 1.2B).  
Prior to organ budding (E8.0-9.5), the early endoderm is a morphologically 
homogenous germ layer, however signaling pathways have already imposed molecular 
differences along its A-P axis to demarcate prospective organ primordia through 
specification of progenitor cell types
42
. Numerous transcription factors are expressed 
along the A-P axis of the endoderm prior to the onset of organ budding, and identify 
subgroups of endodermal progenitors populating the organ anlage (as shown in Figure 
1.2A). A critical question in the field of developmental biology has focused on what 
signaling molecules and pathways act upon the multipotent cells of the endoderm to 
establish discrete A-P zones of competent organ progenitors. The Wnt signaling pathway 
has been heavily implicated in endoderm patterning
47, 48
. 
In the literature, there is a paucity of evidence describing the specific 
contributions of Wnt signaling in the developing mouse endoderm, and specifically the 
foregut endoderm
49
. Additional research is needed to elucidate the mechanisms of Wnt 
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signaling that potentially coordinate foregut development and organogenesis. Moreover, 
studies will need to identify direct transcriptional targets the Wnt signaling pathway 
activates to pattern and instruct organ fate in the multipotent mouse endoderm.  
 
Epithelial-mesenchymal interactions pattern the vertebrate foregut endoderm 
The A-P patterning of the vertebrate endoderm occurs in large part via soluble 
signals derived from adjacent mesodermal tissues
50
. These instructive signals can take the 
form of hormones, growth factors, cytokines, or extracellular matrix molecules, and they 
can activate sets of organ-specific genes
51, 52
. Several studies have demonstrated that the 
splanchnic mesoderm adjacent to the foregut endoderm is necessary for the specification 
of endodermal progenitors giving rise to foregut-derived organs
53-55
. For example, 
mesoderm adjacent to the ventral foregut is critical for liver induction and budding in the 
mouse embryo
43, 56, 57
. Moreover, tissue recombination experiments demonstrate that a 
bipotential liver and pancreas precursor in the foregut endoderm is directly influenced by 
the presence or absence of local mesenchymal cues, indicating that the presence of local 
signals emitted from the mesoderm underpin endodermal progenitor specification
58
. 
Recent studies demonstrate that Wnt ligands produced in the splanchnic 
mesoderm are crucial in coordinating the development of vertebrate endoderm 
derivatives in a tightly regulated temporal fashion. Several Wnts are expressed in the 
mesoderm surrounding the foregut and midgut
59, 60
, and misexpression of Wnt1 and 
Wnt5a in the mouse embryo strongly suggests that paracrine Wnt signaling patterns the 
adjacent foregut and midgut during pancreas progenitor specification and 
differentiation
61
. In zebrafish, wnt2b expression in the lateral plate mesoderm is required 
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for liver progenitor specification, and loss of wnt2b expression results in liver agenesis
48
. 
In the invertebrate system of drosophila, Wnts expressed in the lateral mesoderm have 
been shown to regulate patterning of the gut endoderm
62
. These data indicate that Wnt 
signaling is an evolutionarily conserved paracrine signaling mechanism coordinating the 
development of endoderm-derived tissues. 
Studies carried out in chick and Xenopus models also demonstrate that Wnts 
expressed in the mesoderm pattern the endoderm. Wnt signaling in conjunction with 
Fibroblast growth factor (FGF) signaling suppresses foregut fate in endoderm progenitors 
and concomitantly promotes hindgut fate
47, 50, 63
. Conversely, inhibiting Wnt/!-catenin 
activity in the Xenopus posterior endoderm results in the appearance of ectopic liver 
progenitors and activation of liver-specific genes in the presumptive intestine. 
Surprisingly, slightly later in development, Wnt and FGF signaling promote the 
development of foregut derivatives
47
. Thus, the spatial and temporal characteristics of 
Wnt paracrine signaling occurring between the vertebrate splanchnic mesoderm and 
foregut endoderm is dynamic and appears to directly impact the sequence and location of 
organ formation.  
Altogether, the published data indicate that different Wnt receptor-ligand 
combinations and their accompanying levels of expression are likely to create distinct 
patterns and thresholds of Wnt activity that will coordinate foregut patterning through the 
specification of endodermal progenitors. Further investigations into the role of Wnt 
paracrine signaling between the splanchnic mesoderm and adjacent foregut endoderm 
will be critical for a complete understanding of the role of this pathway in mouse foregut 
progenitor specification and organogenesis. 
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Epithelial-mesenchymal interactions regulate the development of lung progenitors in the 
foregut endoderm 
In agreement with the studies examining liver and pancreas progenitor 
development, several lines of in vivo and in vitro experimental evidence suggest that lung 
progenitor specification and bud outgrowth from the foregut endoderm also rely on non-
cell autonomous paracrine signaling with the adjacent splanchnic mesoderm. Studies in 
which embryonic lung mesoderm is grafted onto heterotypic epithelial cells and tissue 
demonstrate the ability of early embryonic lung mesoderm to induce robust branching 
and de novo expression of lung-specific genes
64-66
. Patterning of the foregut region at the 
site of the presumptive tracheoesophageal bifurcation depends in part on Transforming 
growth factor ! (TGF-!) signals secreted from the adjacent mesoderm
10, 67
.  
Gene targeting experiments have demonstrated that FGF-10 signaling in the 
splanchnic mesoderm is absolutely necessary for inducing lung bud development in the 
foregut endoderm. Mice homozygous mutant for either Fgf10 or its cognate 
endodermally expressed receptor Fgfr2 exhibit severely disrupted lung development with 
no main-stem bronchial development
68-70
. Interestingly, the levels and spatial 
characteristics of FGF and FGF receptor (FGFR) expression in both the splanchnic 
mesoderm and ventral foregut endoderm direct specification of either liver or lung 
progenitors
54
. This finding suggests that specification of foregut endoderm progenitors is 
significantly influenced by the presence of local mesodermal paracrine signaling factors 
in conjunction with the expression of distinct types and combinations of cell surface 
receptors in the endoderm. 
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Crosstalk between Sonic hedgehog (Shh) signaling expressed in the endoderm 
and its targets in the adjacent splanchnic mesoderm also regulate early lung endoderm 
development. Mice that are Shh
-/-
 homozygous mutant form a trachea, but lung branching 
is severely disrupted
71
. Additionally, loss of expression of the Shh-responsive 
transcription factors Gli2 and Gli3 in the embryonic mesoderm yields embryos with 
severe defects throughout lateral mesoderm-derived structures including loss of the 
esophagus, trachea, and lungs
72
.  
 
Activation of a transcriptional network establishes lung endoderm progenitor identity in 
the foregut 
The paracrine signaling occurring between the splanchnic mesoderm and foregut 
endoderm regulates the specification of lung endoderm progenitors through upregulation 
of a transcriptional network governing lung endoderm progenitor identity. Various 
classes of transcription factors — including the GATA-family members (GATA6) and 
Forkheads (Foxa1 and Foxa2) — are expressed in the presumptive lung primordium of 
the foregut endoderm and regulate the development of early lung progenitors
73, 74
. 
Compound mutant mouse models abolishing Foxa1 and Foxa2 function indicate that 
these two genes cooperate to establish competency of the foregut endoderm to gives rise 
to its derivatives including the lung
75
. GATA6 is expressed in lung epithelial progenitors 
and is required for their survival at the onset of branching morphogenesis
74, 76
.  
The transcription factor Nkx2.1 is the earliest known marker of lung progenitor 
cells distinguishing the primitive tracheal and lung endoderm field in the anterior 
foregut
44
 (Figure 1.3A). Of note is that Nkx2.1 is expressed in thyroid precursors during 
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organogenesis, and therefore Nkx2.1 is not a lung progenitor-specific transcription 
factor
77
. Targeted disruption of the Nkx2.1 gene has demonstrated that it is not required 
for lung specification, suggesting that Nkx2.1 expression is activated by other 
unidentified primary signals that induce lung specification
44, 77
.  
 
What factor(s) mediate lung progenitor specification in the foregut endoderm? 
The specific signaling events and tissue interactions that commit the multipotent 
foregut endoderm to a lung cell fate prior to the onset of morphogenesis are under 
increasing scrutiny in large part due to new and better mouse models. Overall, the 
evidence published thus far demonstrates a prominent role for the splanchnic mesoderm 
as a critical signaling center for the specification and maintenance of lung endoderm 
progenitors in the adjacent foregut. However, the question still remains whether a single 
gene contributes to the establishment of the lung endoderm primordium and whether 
there is a lung specific transcription factor mediating the entire lung morphogenesis 
program.  
Despite the drastic disruptions to the lung morphogenesis program in the 
aforementioned genetic models, with the exception of the Gli2/3 compound mutants, 
specification of the early lung and tracheal endoderm still occurs. The presence of 
Nkx2.1-expressing lung progenitor cells in the absence of these factors begs the question 
of what other signal(s) direct specification of lung progenitors in the foregut, and are 
those signals coming directly from the adjacent mesoderm? The Wnt/!-catenin signaling 
pathway represents an intriguing and plausible candidate in early lung specification and 
morphogenesis, given its critical role in the establishment of other foregut derived tissues. 
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Several Wnt ligands are expressed in the splanchnic mesoderm flanking the ventral 
foregut endoderm at the appropriate locations and developmental timepoints to mediate 
lung progenitor specification and development. However, the answer as to whether Wnt 
ligands regulate these processes awaits new genetic mouse models to address this 
hypothesis. 
 
Development of the mouse lung primordia 
Lung morphogenesis in mice has been categorized into five developmental time 
periods corresponding to histological and structural progressions
78
 (Table 1.1). For such 
an elaborate vital organ, the lung has modest beginnings: it develops initially from the 
tracheal outpocketing of the anterior foregut endoderm (outlined in Figure 1.3). 
Specification of lung progenitors in the mouse foregut endoderm occurs around E9.0. 
Lung progenitors can be detected by in situ hybridization as a population of Nkx2.1-
expressing cells in the ventral aspect of the laryngotracheal groove of the foregut 
endoderm
44
. The dorsal aspect of the anterior foregut serves as the esophagus primordium 
and is denoted by robust expression of the transcription factor Sox2
79
 (Figure 1.3A).  
After specification, the ventral Nkx2.1-positive portion of the endoderm tube 
undergoes morphogenesis to bifurcate and from the trachea, and by E11.5 the septation is 
complete with a defined trachea and esophagus (Figure 1.3B). At E10.5, the two 
primitive lung buds are comprised of three cell layers: the inner epithelium (derived from 
the endoderm), the surrounding mesenchymal stroma, and a thin outer mesothelium
80
. 
Mesenchymal cells encompass the primitive lung epithelium as it undergoes repetitive 
terminal and lateral branching during branching morphogenesis invading the splanchnic 
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mesenchyme surrounding the foregut to give rise to an arborized network of airways
81
 
(Figure 1.3C). In vivo cell lineage analysis using an inducible cre recombinase mouse 
model has shown that there are two distinct non-overlapping lung progenitor cell 
populations in the foregut endoderm, which separately contribute to the proximal 
conducting airway epithelium and distal airway epithelium
82
. The tracheal endoderm 
continues to express Nkx2.1 throughout embryonic development
83
.  
 
Epithelial-mesenchymal signaling drives lung branching morphogenesis  
Branching morphogenesis in the mouse lung continues after primary budding 
through E17.0, resulting in the formation of the bronchi, bronchioles, and distal 
alveolated airways
84
. Reciprocal mesenchymal-epithelial interactions are absolutely 
essential to promote and sustain this process for appropriate proximal-distal growth and 
cell differentiation
80, 85-88
. The primary driver of the lung branching morphogenesis 
program is localized expression of the chemoattractant factor FGF-10 in the mesenchyme 
adjacent to the branching epithelial tubules, which express FGFR-2
89, 90
. Feedback 
signaling mediated by Sprouty2, an FGF-10-FGFR-2 inhibitor expressed in the tips of the 
branching epithelium, controls the size and shape of the epithelial bud
91, 92
. Experiments 
conducted in lung organ cultures also suggest that Shh and Bone morphogenetic protein 
(BMP) co-expression in the distal epithelial tips serves to progressively down-regulate 
FGF-10 expression to limit bud outgrowth
93-95
.  
In the current model of lung epithelial branching and patterning, there is a distinct 
compartment of proliferative multipotent cells located at the distal epithelial tips 
expressing the transcription factor Id2, which is only expressed in embryonic distal 
 
 
13 
epithelial cell populations
96
. The maintenance and proliferation of these multipotent cells 
is coordinated by crosstalk between several pathway molecules expressed in both the 
branching epithelial bud and adjacent distal mesenchyme, including Wnts, FGFs, Shh, 
and BMP/TGF-! members
95, 97-99
. The resulting gradient and spatial organization of 
molecules generated as the tips elongate restricts multipotency to the distal tip cells. As 
the epithelial tubules elongate and branch, the progeny of the tip cells continue to divide 
and undergo differentiation to give rise to all of the cell types of the bronchi and 
bronchioles
96
.  
 
The primitive lung epithelium differentiates into multiple cell types  
Coincident with lung outgrowth and branching morphogenesis is proximal-distal 
patterning of the developing airway epithelium. In the proximal conducting airways, the 
epithelium differentiates into various cell lineages including those of the secretory cell 
types (Clara cells and goblet), ciliated cells, and neuroendocrine cells
1
. In the distal 
airways, the terminal epithelial buds branch and dilate to form the presumptive alveolar 
acini (Figure 1.3C). These distal epithelial cells differentiate into either the gas-exchange 
alveolar cell type I, or the surfactant secreting alveolar cell type II
100
 (AECI/II). 
Differentiation of epithelial cells occurs in a proximal-distal direction with the secretory 
Clara and ciliated cell types appearing around E14.5-E15.5 in the proximal airways. In 
the distal airways, the alveolar epithelial cell types AECI and AECII differentiate 
perinatally and through the first week of postnatal life
101
.   
Many of the transcription factors expressed in lung endoderm progenitors and 
required for their survival and differentiation are also required in the latter stages of 
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epithelial development. Genetic deletion of Nkx2.1 and Foxa2 after the onset of 
branching morphogenesis inhibits maturation of peripheral airways leading to respiratory 
failure at birth
102, 103
. Genetic deletion of Gata6 or expression of a dominant-negative 
GATA6 fusion protein in the developing airway epithelium demonstrates that GATA6 is 
also required in the distal compartment during late alveolar epithelial differentiation
76, 104
. 
Notably, branching morphogenesis is not significantly impaired in these mutant models, 
indicating that in later stages of development, the role of these transcription factors is 
restricted primarily to airway epithelial cell differentiation.  
 
Mesenchymal signaling influences proximal-distal patterning of the airway epithelium 
The concurrent growth and branching of the epithelium in juxtaposition with the 
developing mesenchyme establishes signaling centers along the A-P axis that act to 
pattern both tissue compartments in a reciprocal fashion
80, 90
. Tissue recombination 
studies first indicated the necessity of epithelial-mesenchymal tissue interactions to 
promote lung epithelial patterning. In culture, embryonic lung epithelium is unable to 
survive more than seventy-two hours without the presence of peripheral mesenchyme. 
This suggests that the cells in the distal lung mesenchyme are releasing soluble factors 
required by the epithelium for growth and differentiation
105, 106
. Further investigations 
into this observation revealed that FGF members can replace the cytodifferentiation-
inducing function of the distal mesenchyme in recombination experiments
107, 108
. 
Tissue recombination experiments reinforce the existence of molecular A-P 
differences in the mesenchyme along the developing respiratory tract. In vitro studies 
indicate that epithelial progenitors are capable of differentiating into alternative airway 
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epithelial cell types in response to molecular cues originating from different sections of 
dissected lung mesenchyme
106, 109
. These varying sections influence proximal versus 
distal identity in the airway epithelium
65, 109, 110
. One identified factor expressed in the 
mesenchyme that mediates distal identity of epithelial progenitors is Wnt5a. Genetic 
studies in the mouse lung demonstrate that Wnt5a misexpression disrupts key patterning 
factors in the distal signaling center including Shh, FGF-10, and BMP-4, leading to 
airway branching and differentiation defects
97, 98
. These results illustrate the 
interconnectedness of the signaling interactions between the developing lung epithelium 
and mesenchyme, and also highlight a critical role for paracrine Wnt signaling in 
development of the lung epithelium. 
 
The role of Wnt/!-catenin signaling in patterning the developing lung epithelium 
Several Wnt ligands and signaling components of the !-catenin pathway are 
expressed in embryonic lung epithelial and mesenchymal cell types
111, 112
, and the 
importance of epithelial-mesenchymal paracrine signaling suggests that the Wnt/!-
catenin signaling pathway contributes a critical role in these signaling interactions. 
Transgenic mouse models including BAT-GAL and TOP-GAL demonstrate canonical 
Wnt/!-catenin signaling activity in the developing lung epithelium from E9.5-E11.5, with 
sporadic activity in a subpopulation of distal airway epithelial cells at E18.5
113-115
. These 
observations demonstrate that canonical Wnt/!-catenin is active during early lung 
development and may be influencing epithelial differentiation. 
The contributions of Wnt/!-catenin signaling activity to epithelial patterning have 
been investigated through genetic deletion or inhibition of !-catenin in the developing 
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airway epithelium and mesenchyme. The loss or suppression of epithelial !-catenin 
signaling leads to the loss of peripheral epithelial progenitors and dysregulation of 
proximal-distal patterning of the airway epithelium
115, 116
. Conversely, the expression of a 
constitutively active !-catenin-Lef1 fusion protein in early lung epithelial cell types leads 
to hyperplasia of the airway epithelium with a parallel loss of fully differentiated airway 
cell types
114
. Interestingly, activated !-catenin signaling also induces a switch in cell 
lineage commitment with distal lung epithelial cells expressing intestinal markers. This 
observation suggests that persistently high levels of !-catenin signaling can induce 
transdetermination of lung epithelial progenitor cell types, or perhaps induce 
dedifferentiation back to an early type of embryonic endodermal progenitor. Finally, 
genetic deletion of !-catenin throughout the developing mesenchyme disrupts epithelial 
cell patterning, indicating that mesenchymal Wnt/!-catenin signaling also regulates 
epithelial differentiation
117
. 
Collectively, these results demonstrate a critical role for Wnt/!-catenin signaling 
in coordinating lung proximal-distal patterning. Given that there are multiple Wnts 
expressed in the lung, and !-catenin is expressed in multiple cell types of the lung, this 
raises the possibility for numerous types of signaling interactions between the epithelium 
and mesenchyme both cell autonomously and non-autonomously. Therefore, the precise 
influence and mechanisms of Wnt/!-catenin signaling on the lung epithelium is likely to 
be complex and comprise distinct temporal and spatial signaling interactions along the A-
P axis. 
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Development of mesenchymal-derived components of the lung 
In the early lung bud, the condensing lung mesenchyme will go on to differentiate 
into several tissue types including smooth muscle (SM), and vascular and lymphatic 
vessels. Cell types comprising these lineages include airway and vascular smooth muscle 
cells, endothelial cells, myofibroblasts, lipofibroblasts, and stromal fibroblasts
118-121
. SM 
development is one of the notable patterning events occurring in lung mesenchymal 
development. At the level of the mainstem bronchi, SM develops partially around the 
airway on the dorsal surface with cartilaginous rings forming on the ventral surface. 
Slightly more posterior in the remaining proximal airways, SM forms around the entire 
epithelium, and in the more distal airways SM is absent. In the developing pulmonary 
vasculature, SM surrounds the larger blood vessels
122
.  
Airway smooth muscle development (ASM) closely succeeds the growth and 
differentiation of the airway epithelium temporally and spatially. At E11.5 in the mouse, 
a SM layer envelops the trachea and primary lung buds, and SM continues to develop 
around the proximal epithelial tubules
123
. In the current model, one source of ASM 
originates from a distal pool of Fgf10-expressing mesenchymal cells (Figure 1.4). These 
distal cells proliferate and passively translocate (or perhaps actively migrate) to surround 
the proximal airways by continued epithelial tube outgrowth and branching. The Fgf10-
expressing cells now in close proximity to the airway tubules are exposed to pro-
myogenic signals diffusing from the distal bud epithelium, which activate SM 
differentiation
95, 124, 125
. Continued exposure to these pro-myogenic signals from the 
adjacent epithelium as the cells consolidate around the airways in conjunction with 
downregulation of FGF-10 signaling promotes maturation of the ASM
126
. 
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Epithelial signaling influences lung mesenchymal development 
In vitro studies demonstrate that cultured embryonic lung mesenchyme fails to 
develop and differentiate in the absence of lung epithelium
127, 128
. Subsequent studies 
reveal that the two epithelial compartments of the lung — the inner endoderm and outer 
mesothelium — both signal to and coordinate the development of the lung mesenchyme 
and its derivatives.  
Genetic evidence demonstrates that Shh expressed from the developing lung 
epithelium is a critical epithelial factor signaling to the adjacent mesenchyme to regulate 
gene expression through its receptor Patched (Ptc) and downstream transcriptional 
activators Gli2 and Gli3
129, 130
. Shh
-/-
 null mutant lungs are hypoplastic with significantly 
decreased proliferation and downregulation of critical factors in the mesenchymal 
compartment
71
. Combinatorial genetic loss of the transcriptional activator molecules Gli2 
and Gli3 also results in a significant loss of lung mesenchymal tissues
72, 85, 131
. 
Interestingly, transgenic overexpression of Shh in the lung epithelium leads to increased 
proliferation in the adjacent mesenchyme and upregulates expression of mesenchymal 
targets including Ptc and Bmp4, indicating that Shh is a broad regulator of signaling 
activities in the mesenchymal compartment
80, 93
.  
The outer mesothelium layer expresses FGF-9 and recent investigations 
demonstrate that FGF-9 signaling will inhibit the response of the mesenchyme to Shh 
expressed from the endoderm. Loss of FGF-9 signaling in the mesothelium leads to 
decreased stromal proliferation, ultimately yielding a lung with significantly reduced 
mesenchymal mass
132, 133
. Cumulatively, these gain- and loss-of-function experiments 
highlight the significance of the signaling interplay between both epithelial compartments 
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and the mesenchymal compartment during lung morphogenesis. The reciprocal paracrine 
signaling between all three tissues appears to directly impact the size and fate of a 
mesenchymal progenitor pool in the distal lung. 
Paracrine signaling between the developing epithelium and mesenchyme is 
critical for SM development in the lung. The distal tips of the epithelial buds secrete pro-
myogenic signals including Shh and BMP-4 to the adjacent mesenchyme during 
branching morphogenesis to promote ASM development
80, 95, 124
. Misexpression of these 
signaling molecules often impairs the differentiation of adjacent immature smooth muscle 
cells (SMCs). In addition to the loss of proliferation and target gene expression in the 
mesenchyme of Shh
-/-
 null mutant lungs, there is also a loss of SM development
71, 93
. 
Fgf10 hypomorphic mice demonstrate that epithelial BMP-4 expression is a target of 
FGF-10 signaling from the adjacent mesenchyme, and the subsequent activation of BMP-
4 signaling is critical for ASM differentiation
125
.  
 
The role of Wnt/!-catenin signaling in patterning lung smooth muscle 
Recent studies indicate that Wnt/!-catenin signaling is active and plays a role 
during SM development in the lung. From E14.5 to E18.5, transgenic mouse models 
show Wnt/!-catenin signaling activity in the developing ASM
115
. Canonical Wnt/!-
catenin signaling from the lung epithelium appears to be critical for SM development in 
the lung. Loss of the epithelial-expressed Wnt7b gene leads to fatal interruptions in lung 
vascular smooth muscle (VSM) development
134
. Furthermore, treating lung explants with 
the canonical Wnt signaling inhibitor Dickkopf-1 (Dkk-1) impairs SM gene 
expression
135
. 
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More recent studies demonstrate that genetic deletion of !-catenin in the 
mesenchymal compartment impairs the amplification of Fgf10-expressing cells and 
results in a significant loss of ASM
136
. Moreover, genetic deletion of !-catenin in early 
lung SMCs also results in a significant loss mature SM
22
. Interestingly, Cohen et al. 
showed that in utero administration of the activating Wnt/!-catenin signaling 
pharmacological agent LiCl enhanced SM development in wild-type embryos, suggesting 
that Wnt/!-catenin signaling is sufficient to promote SM development in the lung
22
. 
Together, these studies demonstrate that Wnt/!-catenin signaling is critical for SM 
development in the lung.  
Despite the evidence in the literature implicating several signaling pathways in 
SM differentiation, there is still a considerable lack of information on the development of 
early SMCs in the lung. The Wnt/!-catenin signaling pathway represents an appealing 
candidate pathway regulating early-stage SMCs because of its temporospatial patterns of 
expression in the embryonic lung. Currently in the lung field, Wnt7b is the only canonical 
Wnt ligand reported to play a critical role in SM development, and Wnt7b paracrine 
signaling specifically contributes to VSM development
134
. The loss of ASM in !-catenin 
loss-of-function models suggests that other Wnt ligands expressed in the lung are 
contributing to SM development. Therefore, the generation and examination of additional 
loss-of-function mouse models for candidate Wnt ligands expressed in the lung may 
reveal additional roles for Wnt signaling in SM development. 
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Wnt ligands expressed in the mouse lung 
Several Wnt ligand-encoding genes are expressed in the developing mouse lung 
including Wnt2, Wnt2b, Wnt5a, Wnt7b, and Wnt11. Wnt7b is a canonical Wnt ligand 
expressed at high levels in the developing airway epithelium
134
. Wnt5a is expressed in 
both the developing mesenchyme and epithelium at later stages of lung development, 
with higher levels of transcript expression observed in and around the distal branching 
airway epithelium
97
. Wnt11 is expressed diffusely at low levels throughout the embryonic 
lung epithelium and mesenchyme
112, 137
. 
Genetic knockout mouse models carrying targeted disruptions of Wnt ligand-
encoding genes expressed in the lung have been generated and many are reported to have 
defects. Wnt5a knockout mice die shortly after birth from respiratory failure, and exhibit 
late stage lung branching defects with a parallel loss of maturation of distal lung 
epithelial and mesenchymal cell types
97
. Wnt11 knockout mice also suffer from perinatal 
lethality and display kidney branching defects with no reported lung phenotype
138
, 
suggesting other Wnts in the lung may function redundantly with Wnt11. Wnt7b 
knockout mice die perinatally and exhibit severely hypoplastic lungs with decreased 
epithelial and mesenchymal proliferation in addition to VSM defects
134, 139
. 
Expression of Wnt2 and Wnt2b in the mouse lung 
The Wnt2 and Wnt2b ligands are expressed throughout lung organogenesis and 
more recently have come under scrutiny in our laboratory as compelling candidates for 
the regulation of lung morphogenesis. Wnt2b is a second member of the Wnt2 family, 
sharing approximately 70% amino acid identity with Wnt2
140
. Both are expressed in 
overlapping spatiotemporal patterns in the splanchnic mesoderm and lung mesenchyme 
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during lung development. Wnt2 and Wnt2b are initially expressed around E7.5-E9.5 in 
the splanchnic mesoderm surrounding the foregut involution
140, 141
. The two genes are 
later expressed throughout the developing lung mesenchyme around E11.5, and at sites 
within the heart and vasculature
142
. We have observed that Wnt2 is expressed at higher 
levels than Wnt2b in the lung mesenchyme, and the robust expression of Wnt2 persists to 
the perinatal stages of embryonic development, while Wnt2b expression levels remain 
much lower
143
.  
Unfortunately, previously generated mouse models carrying null alleles of Wnt2 
and Wnt2b have not revealed clear roles for Wnt2 and Wnt2b signaling in lung 
development. Monkley et al. generated a Wnt2 knockout mouse model, and Wnt2
-/-
 
homozygous mutant mice display runting in the litters and placental defects, with no 
observable lung phenotype
141
. RT-PCR performed on lung and heart tissue from these 
Wnt2 knockout
 
mice indicated that this model was a hypomorph due to the presence of 
residual Wnt2 transcripts. With respect to Wnt2b, our laboratory has analyzed a 
collaborator’s Wnt2b knockout mouse model, and these mice do not exhibit any lung 
developmental defects
143
. One interpretation for the lack of lung defects in these 
knockout models is that Wnt2 and Wnt2b are functioning redundantly during lung 
development. However, the lack of a lung phenotype in the reported Wnt2 knockout 
mouse model is also likely to reflect the fact that the mutant allele is a hypomorph.  
 
Potential functions of Wnt2 and Wnt2b signaling in the lung 
These confounding factors have left many unanswered questions concerning the 
role of the Wnt2 signaling lung development, and this provided the impetus for my 
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investigations into the contributions of the Wnt2 and Wnt2b ligands to lung development. 
Several unanswered question remain regarding their function in lung development. First, 
what are the roles of the Wnt2 and Wnt2b ligands in the splanchnic mesoderm and 
developing lung mesenchyme? Second, are Wnt2 and Wnt2b functioning redundantly in 
these tissues? Third, are these ligands signaling canonically through !-catenin, or non-
canonically in their target tissues? And finally, are Wnt2 and Wnt2b signaling in a 
paracrine and/or autocrine manner, and what are the downstream targets? In order to 
address these questions, our lab recently generated a new Wnt2 knockout mouse model, 
which exhibits a complete loss of Wnt2 expression at the transcript and protein level. 
Additionally, we were granted permission to use and investigate a Wnt2b knockout model 
from a collaborating lab. The resulting analysis of the Wnt2 and Wnt2b knockout models, 
which is described in this thesis, provides novel insight into the contributions of these 
ligands during lung specification and morphogenesis. 
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Table 1.1: Progression of lung development in mice. 
 
Period Developmental 
Timepoints 
Description 
Embryonic E9.5-E11.5 Septation of the trachea and esophagus, 
formation of primitive lung buds, first 
round of branching morphogenesis to yield 
primary bronchi 
Pseudoglandular E11.5-E16.6 Continued branching morphogenesis giving 
rise to network of bronchiolar airway 
tubules and buds; vasculogenesis and 
innervation commence 
Canalicular E16.6-E17.4 Formation of the distal pulmonary acinus 
(saccules) and associated vascular network; 
epithelial differentiation commences 
Terminal saccular E17.4-P5 Dilation of the distal airway space, distal 
epithelial differentiation, surfactant 
synthesis  
Alveolar P5-P30 Alveolar growth and septation, maturation 
of pulmonary vasculature 
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Figure 1.1: The Wnt signaling pathway. 
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Figure 1.1: The Wnt signaling pathway. 
(A) Overview of the Wnt signaling pathway illustrates that Wnt ligands can activate at 
least three distinct downstream signaling pathways. In the canonical !-catenin pathway, 
Wnt ligand binding to a Fzd/Lrp co-receptor complex activates the intracellular protein 
Disheveled (Dvl), which leads to the inhibition of the !-catenin degradation complex 
(composed of Gsk3!, Axin2, and APC) and accumulation of !-catenin in the cytoplasm. 
!-catenin then enters the nucleus to interact with members of the Lef/Tcf family of 
transcription factors to activate target gene transcription. In !-catenin independent 
pathways, Wnt ligand binding to a Fzd receptor can activate either intracellular calcium 
signaling, which influences a variety of cellular processes, or activate RhoA/JNK 
signaling to mediate cell movement.  
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Figure 1.2: Endoderm development in the mouse. 
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Figure 1.2: Endoderm development in the mouse. 
(A) Schematic of the developing mouse embryo and endoderm at E8.0 after gastrulation 
occurs (E6.0-E7.5). At the end of gastrulation, the primitive endoderm germ layer exists 
as a sheet of cells that quickly undergoes a series of morphogenetic movements to form 
the primitive endoderm tube (purple). The primitive endoderm is divided into three 
anatomical sections: the anterior foregut, midgut, and posterior hindgut. Despite its 
homogenous appearance along the A-P axis of the developing embryo, molecular 
differences already denote primitive organ domains. In the foregut, transcription factors 
including the homeodomain genes Nkx2.1 [also known as thyroid transcription factor 1 
(Titf1)]
144
 and Hex (hematopoietically expressed homeobox gene)
145
, as well as the paired 
box (Pax) genes Pax8
146
 and Pax9
146, 147
, demarcate the thyroid/parathyroid, lung, and 
liver domains, respectively. In the midgut, the transcription factors Pax4
148
 and Pax6
149
, 
Nkx2.2
150
, Islet-1
151
, and Pdx1
152, 153
are expressed in the presumptive stomach, pancreas, 
and duodenum domains, respectively. Cdx2, a caudal homologue and member of the 
axial patterning Protohox gene cluster, is expressed in the hindgut
154
. (B) By E10.5, 
primitive organs have begun to bud and develop from the endoderm. The foregut 
endoderm gives rise to the lung, stomach, liver, and ventral pancreas. The midgut 
endoderm also contributes to the stomach and dorsal pancreas and duodenum of the 
intestines. The remaining hindgut gives rise to the intestines. 
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Figure 1.3: Lung organogenesis in the mouse. 
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Figure 1.3: Lung organogenesis in the mouse. 
(A-C) Schematic of lung development. (A) Around E9.0, tracheal/lung progenitors are 
specified in the ventral foregut endoderm as denoted by the expression of Nkx2.1, the 
earliest marker of lung identity. Subsequently, morphogenetic movements initiate the 
bifurcation of the tracheal endoderm (Nkx2.1 positive) and the esophageal endoderm 
(Sox2 positive). (B) By E11.5, tracheoesophageal septation has completed and lung 
morphogenesis commences with endoderm outgrowth to yield two primary lung buds. 
Branching morphogenesis promotes repetitive outgrowth and branching of the lung buds 
to yield an arborized network of airways (C). The proximal airways comprise the primary 
bronchi and distal bronchioles, while the distal alveolar compartment comprises the distal 
airways.  
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Figure 1.4: Airway smooth muscle development in the lung. 
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Figure 1.4: Airway smooth muscle development in the lung. 
Overview of smooth muscle (SM) development in the mouse lung. A sub-mesothelial 
pool of proliferating immature SMCs expressing FGF-10 and SM22" are apparent in the 
lung bud by day E11.5. As the lung bud undergoes branching morphogenesis, the 
mesenchyme condenses to bring the FGF-10
+
/SM22"
+
 SMCs in close proximity to the 
branching epithelial bud, which is secreting pro-myogenic factors including Shh and 
BMP-4. The cells coalesce around the airways and continue to differentiate in response to 
epithelial signaling, flattening to resemble fibroblast-like mature airway smooth muscle 
(ASM). During this process, the cells continue to express SM22" and now SMA, a 
mature ASM marker. Down-regulation of FGF-10 is thought to propel full differentiation 
of ASM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
33 
Chapter 2: A role for Wnt2 in lung airway smooth muscle development 
A majority of the data presented in this chapter is part of a forthcoming manuscript. The 
data describing the Wnt2 expression patterns, Wnt2 knockout mouse model, and Wnt2
-/-
 
null mutant hypoplasia phenotype are published in Goss et al., 2009. 
 
Summary 
In Chapter 1, I gave an overview of the current concept of airway smooth muscle 
(ASM) development in the mouse embryonic lung. Although several signaling pathways 
have been identified as important for smooth muscle (SM) development and maturation 
after the onset of branching morphogenesis, there is less data describing the pathways 
regulating the early stages of SM development in the lung mesenchyme. In this chapter, I 
identify the Wnt2 ligand as a critical regulator of SM development. I show that the loss of 
Wnt2 leads to the down-regulation of a transcriptional and signaling network governing 
early SM development. This loss results in impaired differentiation of the primitive lung 
mesenchyme into an immature SM lineage that gives rise to ASM.  
 
Introduction 
Disruptions to SM development in humans can lead to chronic health 
complications including asthma and pulmonary hypertension
155, 156
. Understanding the 
signaling pathways coordinating the various specification and differentiation processes 
occurring during SM development are critical to a complete understanding of lung 
development as well as pathogenesis in the post-natal lung. Aberrant Wnt signaling is 
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implicated in several lung diseases including asthma
157
, and therefore deciphering the 
contributions of Wnt signaling during lung development may offer compelling correlates 
to its contributions to the diseased state.  
As I introduced in Chapter 1, the primitive lung mesenchyme gives rise to several 
cell lineages including smooth muscle cells (SMCs), which will go on to form a sheath 
around the airways and vasculature in the maturing embryonic lung. SM development is 
an intriguing patterning event occurring in the mouse lung because the origins of SMC 
types are still unclear and the pathways regulating proliferation, migration, and 
differentiation of primitive SMCs are complex and unresolved. Currently, there are no 
markers distinguishing the origins of airway and vascular smooth muscle (ASM and 
VSM), thus the identity of a SMC progenitor giving rise to ASM and/or VSM remains 
elusive. There are data suggesting that two subpopulations of lung mesenchyme give rise 
to SMC lineages that contribute separately to ASM and VSM. Genetic fatemapping 
experiments indicate that a subpopulation of mesothelial cells in the developing lung 
pleura contribute to VSM in the mouse lung, and not ASM
158
. In contrast, an enhancer 
trap transgenic mouse line expressing lacZ from the Fgf10 locus identified a 
subpopulation of Fgf10-expressing distal mesenchymal cells that condense around 
bronchial airways and give rise to ASM
125
.   
Several signaling pathways are known to be critical in lung SM development. 
FGF-10 signaling is important for ASM development and mediates this process in part, 
through signaling interactions with the epithelium. FGF-10 signaling from the 
mesenchyme activates a gene expression program in the adjacent developing epithelium, 
which signals in a reciprocal fashion back to the mesenchyme to direct SMC 
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differentiation
125
. The pro-myogenic signals expressed in the developing airway 
epithelium include Shh and BMP-4, and these factors direct SMC differentiation along 
the branching epithelial tubule as Fgf10-expressing cells condense around the primitive 
airway
159, 160
 (see Figure 1.4). FGF-9 signaling from the mesothelium is also reported to 
mediate the development of immature SMCs in the distal mesenchyme by limiting the 
differentiation response of the mesenchyme to Shh signaling
133
. 
Published data demonstrate that canonical Wnt/!-catenin signaling contributes to 
SM development in the lung. Transgenic canonical Wnt/!-catenin reporter mice show !-
catenin signaling activity in developing ASM cells, and this activity colocalizes with the 
mature SMC marker smooth muscle "-actin (SMA)
115
. Genetic deletion of !-catenin in 
primitive SMCs leads to a significant loss of mature SM in the lung
22
. Wnt7b is a 
canonical Wnt ligand expressed in the developing epithelium, and Wnt7b knockout mice 
display perinatal pulmonary hemorrhaging owing to disrupted VSM development
134
. 
Further investigation into the mechanisms of Wnt7b signaling revealed that Wnt7b 
broadly regulates the development of SMCs in the early lung bud mesenchyme
22
. The 
effects on the early SMC population at-large are intriguing in context with the observed 
perinatal VSM defects. These data suggest that epithelial-based Wnt signaling 
preferentially directs VSM development.  
Recently published data also implicates a role for autocrine canonical Wnt/!-
catenin signaling in lung SM development. Genetic deletion of !-catenin in the 
developing lung mesenchyme using a pan-mesenchymal Dermo1-cre driver leads to 
disrupted ASM development
136
. These results differ somewhat from the disrupted SM 
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patterning in Wnt7b
-/-
 null mutants, suggesting that Wnt7b may also signal through a !-
catenin independent pathway to regulate VSM.  
  Wnt2 is a ligand expressed throughout the developing lung mesenchyme. The 
expression pattern of Wnt2 suggests that it may play a role in the development of 
mesenchymal-derived lineages. In this chapter, I examine a recently generated mouse line 
from our laboratory carrying a Wnt2
 
null allele. Examination of Wnt2
-/-
 mice reveals a 
dramatic loss in ASM perinatally, stemming from decreased proliferation and 
differentiation of immature SMCs in the early lung bud. These results suggest that Wnt2 
signaling plays an important role in the development of SM in the mouse lung. 
 
Results 
Expression of Wnt2 during lung development 
Previously published data on Wnt2 expression in the embryonic mouse lung 
indicated that this ligand is expressed throughout lung organogenesis
141
. We confirmed 
this using a Wnt2-specific probe for in situ hybridizations on foregut endoderm and lung 
tissue throughout embryonic development. Wnt2 is first expressed in the mesoderm 
surrounding the ventral aspect of the anterior foregut endoderm from E9.0-E9.5 during 
the period when the lung is specified (Figure 2.1A, B), and continues throughout the 
developing lung mesenchyme with expression persisting up to perinatal timepoints 
140, 141
. 
The expression pattern of Wnt2 suggests that the gene plays a critical role in the 
development of mesenchymal lineages in the lung. To further investigate the role of 
Wnt2 function in lung development, our laboratory generated mice carrying a null allele 
of the Wnt2 gene using homologous recombination in embryonic stem (ES) cells (Figure 
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2.2). Heterozygous mutant Wnt2
+/-
 mice were interbred to generate Wnt2
-/-
 null mutant 
embryos, which were examined for possible lung developmental defects. The majority of 
Wnt2
-/-
 null mutants live to E18.5, but die within a few minutes of birth due to respiratory 
and cardiovascular defects
161
 (Table 2.1).  
 
Loss of Wnt2 leads to lung hypoplasia and down-regulation of pathways required 
for lung development. 
To explore the reason for the perinatal lethality in Wnt2
-/-
 null mutants, 
histological analysis was performed on embryos from E11.5-E18.5. These examinations 
reveal lung hypoplasia in Wnt2
-/-
 null mutants that is apparent throughout the course of 
embryogenesis and postnatally (Figure 2.3A-J). The developing lung mesenchyme is also 
noticeably thinned in Wnt2
-/-
 null mutants (Figure 2.3G-J). Despite the hypoplasia, 
wholemount immunostaining with the pan-epithelial marker E-cadherin shows that 
branching of the terminal airways appears grossly normal in E14.5 Wnt2
-/-
 null lungs 
(Figure 2.3K-N).  
To better understand the cause for the lung hypoplasia, cell proliferation analysis 
was undertaken using a Ki67 antibody to mark proliferating cells. Ki67 immunostaining 
reveals decreased proliferation in both the epithelial and mesenchymal cell compartments 
in Wnt2
-/-
 null lungs (Figure 2.3O-Q). Additionally, several signaling pathways and 
transcription factors known to be important for lung growth and differentiation including 
Fgf10, Nkx2.1, Bmp4, N-myc, and cyclin D1 are reduced in Wnt2
-/-
 null lungs (Figure 
2.3R) 
70, 144, 162-164
. In contrast, proximal-distal patterning of the epithelium is unperturbed 
in Wnt2
-/-
 null lungs, as denoted by expression of SP-C
82
, a marker of distal alveolar 
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epithelial cells, and CC10
165
, a marker of proximal bronchiolar epithelial cells (Figure 
2.3S-V). Together, these data suggest that Wnt2 signaling is important for lung 
development and that loss of Wnt2 signaling disrupts proliferation and expression of 
genes known to regulate lung development, and in particular, disrupts the development of 
the lung mesenchyme.  
 
Wnt2 signaling through !-catenin regulates airway smooth muscle development in 
the lung mesenchyme 
The appearance of a thin mesenchyme in Wnt2
-/-
 null lungs suggests possible 
defects in mesenchymal cell development and differentiation. Closer examination of 
Wnt2
-/-
 null lungs at E18.5 reveals a reduction in SM surrounding the bronchiolar airways 
as demonstrated by the loss in expression of the mature SM marker, SM22" (Figure 
2.4A-D). At high magnification, SM22"-expressing cells are sporadic around the 
airways, producing significant gaps in the SM layer (Figure 2.4C, D). Interestingly, 
SM22" expression in the SM layer of adjacent blood vessels appears unaltered (Figure 
2.4A, B), suggesting no impairment to VSM development.  
The Wnt/!-catenin transgenic reporter mice BAT-GAL and TOP-GAL show 
Wnt/!-catenin signaling activity in the developing lung SM
114, 115
, and Wnt2 is reported 
to signal canonically through the Wnt/!-catenin pathway in the lung
159, 166
. To determine 
if Wnt2 signals through !-catenin in the developing ASM, Wnt2
+/- 
heterozygous mutant 
mice were crossed into the transgenic BAT-GAL reporter background to yield Wnt2
-/-
:BAT-GAL embryos. In E14.5 control BAT-GAL embryos carrying wild-type Wnt2 
alleles, lacZ-positive cells are evident underlying the developing airway epithelium 
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(Figure 2.4E). In the absence of Wnt2, there is a reduction in the number of lacZ-positive 
cells in the presumptive ASM layer, indicating a loss of Wnt/!-catenin activity (Figure 
2.4F). Additionally, expression of the Wnt/!-catenin transcriptional target Axin2 is 
reduced in the primitive ASM layer of E14.5 Wnt2
-/-
 null lungs (Figure 2.4H). These data 
suggest that Wnt2 signals through !-catenin in the lung mesenchyme to mediate proper 
ASM development. However, this does not preclude a potential role for Wnt2 paracrine 
signaling to the adjacent epithelium. 
 
Wnt2 regulates development of the primitive lung mesenchyme and immature 
smooth muscle 
The loss of mature ASM suggests that there is an earlier defect in SMC 
development in the primitive mesenchyme. The reduced proliferation index of the 
mesenchymal compartment in Wnt2
-/-
 null lungs (Figure 2.3 O-Q) is likely one 
contributing factor to a loss in SMC development. However, the loss may also reflect 
disruption to the differentiation of immature SMCs in Wnt2
-/-
 null lungs that give rise to 
ASM.  
SM22" is a highly useful SM marker because it is expressed early in SMC 
differentiation
167
. In E11.5 wild-type embryos, SM22" expression is distinct in a 
population of cells forming around the developing proximal airway (Figure 2.5A). In 
Wnt2
-/-
 null lungs, this expression is reduced (Figure 2.5B), indicating that there is a loss 
of SMC differentiation in the absence of Wnt2 signaling. Quantitative PCR on E11.5 
wild-type and Wnt2
-/-
 null lung buds confirms a significant reduction in SM22" 
expression (Figure 2.5L).  
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PDGFR" and PDGFR! are receptor tyrosine kinases through which members of 
the platelet-derived growth factor family (PDGF) of ligands signal in embryonic 
mesenchyme to regulate proliferation, migration, and differentiation
168
. PDGFR" and 
PDGFR! are broadly expressed in the multipotent mesenchymal cells of the early lung 
bud, and have been shown to be important in the development of SMCs from the lung 
primitive mesenchyme
118, 169
. Both receptors continue to be expressed in mature SM, with 
PDGFR! expressed more strongly in VSM
22, 170
. In E11.5 wild-type embryos, expression 
of PDGFR! is observed in mesenchymal cells that are coalescing around the developing 
airways and vasculature (Figure 2.5C), however in Wnt2
-/-
 null lungs, there is reduced 
PDGFR! expression in the mesenchyme (Figure 2.5D). Quantitative PCR on E11.5 wild-
type and Wnt2
-/-
 null lung buds demonstrates a significant reduction in Pdgfr! expression 
(Figure 2.5K). Overall, these data suggest that loss of Wnt2 function disrupts the 
development of immature SMCs in the early lung mesenchyme. 
 
Wnt2 signaling is necessary for smooth muscle gene expression in the lung 
To assess whether the earliest stages of SMC differentiation are activated in  
Wnt2
-/-
 null lungs, expression levels of the transcription factors myocardin and MRTFB 
were examined. Myocardin is a member of the Myocardin family of Serum Response 
Factor (SRF) co-factors, expressed in the developing and mature SM of several tissues 
including the lung
171
. Myocardin is a critical upstream regulator of myogenesis and in 
primitive SMCs, myocardin transactivates numerous SM differentiation genes including 
SM22" and SMA172, 173. Two other family members expressed in embryonic and adult 
SMCs that potently confer transcriptional activity to SRF to mediate myogenesis are the 
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myocardin-related transcription factors A and B (MRTFA, MRTFB)
174
. MRTFA is 
broadly expressed throughout the developing mouse embryo in multiple tissue types
175
, 
whereas MRTFB exhibits a more cell-lineage restricted expression pattern including 
developing cardiac and immature SMCs
176
.  
At E11.5, in situ hybridizations on wild-type lung tissue show myocardin 
expression around the proximal airway of the primary lung bud (Figure 2.5E). In Wnt2
-/-
 
null lung tissue, there is a reduction in expression of myocardin in the developing ASM 
(Figure 2.5F). Slightly later at E14.5, myocardin expression levels remain lower in the 
ASM of Wnt2
-/-
 null lungs than in wild-type lungs (Figure 2.5G, H). A significant 
reduction in myocardin expression levels is confirmed by quantitative PCR on E11.5 
wild-type and Wnt2
-/-
 null lung bud tissue (Figure 2.5I). Quantitative PCR also 
demonstrates that MRTFB expression is significantly reduced in Wnt2
-/-
 null lung buds 
(Figure 2.5J). The significant reductions in myocardin and MRTFB expression in Wnt2
-/-
 
null lung buds indicates the down-regulation of a myogenic transcriptional program, 
suggesting that there is reduced SMC differentiation in the absence of Wnt2 signaling. 
 
Wnt2 signaling is sufficient to promote smooth muscle development in the lung 
 The loss of early SMC gene expression suggests that Wnt2 signaling regulates 
SMC differentiation from the multipotent mesenchyme, however it is unclear whether 
Wnt2 signaling is sufficient to promote SMC development in the lung mesenchyme.  To 
better understand the effects of Wnt2 signaling on mesenchymal cells, a recombinant 
Wnt2 protein (rWnt2) was used to treat 10T1/2 cells, an immortalized multipotent 
fibroblast-like mouse cell line
177
. Culturing 10T1/2 cells in the presence of rWnt2 for 48 
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hours leads to increased expression of several SMC genes including SM22", SMA, 
myocardin, Pdgfr", Pdgfr!, and Fgf10, as assessed by quantitative PCR (Figure 2.6A). 
Expression of the canonical Wnt transcriptional target gene Axin2 is significantly 
upregulated, indicating that the rWnt2 protein is activating Wnt/!-catenin signaling in a 
mesenchymal cell type.  
To further investigate the in vivo effects of rWnt2 on SMC development, E11.5 
wild-type lung buds were dissected and cultured for 48 hours with either control PBS or 
rWnt2 in a lung explant assay, which closely mimics in vivo development
178
. Explants 
were collected to examine for changes in SMC development by histological methods and 
quantitative PCR. In control lung bud explants, SM22" immunostaining shows 
expression in the presumptive ASM layer (Figure 2.6C). In lung bud explants cultured in 
the presence of rWnt2, SM22" expression is increased around the airways (Figure 2.6D). 
The appearance of increased ASM is complemented by increased expression of 
additional SMC marker genes including SM22", myocardin, MRTFB, Fgf10, Pdgfr!, and 
Pdgfr". The mature SM marker SMA is also increased in the presence of rWnt2, although 
not to the extent of other early SMC markers, suggesting that Wnt2 signaling promotes 
the differentiation and expansion of immature SMCs in the lung mesenchyme, rather than 
full differentiation to a more mature SMC type. 
 
Other mesenchymal-derived lineages in Wnt2
-/-
 null lungs 
 Other cell types in the mouse lung are derived from the developing mesenchyme 
including endothelial and lymphatic cell lineages
179
. The overall poor mesenchymal 
development observed Wnt2
-/-
 null lungs could signify disruption to the development of 
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multiple mesenchymal lineages, and therefore Wnt2
-/-
 null lungs were examined for 
defects in endothelial and lymphatic cell lineages.  
At E18.5, compared to wild-type lung tissue, Wnt2
-/-
 null lungs do not exhibit any 
alteration in the levels or localization of the endothelial cell marker PECAM (Figure 
2.7A, B). Quantitative PCR performed on E12.5 wild-type and Wnt2
-/-
 null lung buds 
tissue reveals only slight reductions in the expression of the endothelial marker genes 
Pecam1 and Flk1 (Figure 2.7C, D). Members of the VEGF family of molecules are 
important for regulating endothelial and lymphatic development in multiple tissue 
types
180
. Several of these members were also analyzed by quantitative PCR on E12.5 
wild-type and Wnt2
-/-
 null lung buds. VEGFA, VEGFC, and VEGFD are expressed in the 
lung during development
181
, and quantitative PCR demonstrates comparable expression 
levels of VegfA and VegfD between wild-type and Wnt2
-/-
 null lung bud tissue (Figure 
2.7E). Interestingly, VegfC expression is significantly reduced in the absence of Wnt2 
function (Figure 2.7G).  Together, these data indicate that the loss of Wnt2 in the 
embryonic lung affects other mesenchymal-derived lineages at the level of gene 
expression, during early developmental timepoints.  
 
Expression of signaling pathways important for smooth muscle development in 
Wnt2
-/-
 null lungs 
 Several signaling pathways have been identified to be critical for SM 
development in the mouse lung including the Shh, BMP, Wnt7b, and FGF-10 signaling 
pathways. Wnt2 is expressed early in the primitive mesenchyme, and Wnt2 signaling may 
lie upstream of these pathways and regulate pathway members to mediate SM 
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development. At E10.5, in situ hybridizations reveal that Wnt7b expression is reduced in 
Wnt2
-/-
 null mutant foreguts (Figure 2.8A, B). Quantitative PCR on E11.5 wild-type and 
Wnt2
-/-
 null lung buds demonstrates that Wnt7b expression levels are approximately fifty 
percent lower in Wnt2
-/-
 null lungs than wild-type lungs (Figure 2.8I). These data suggest 
that Wnt2 may be signaling in a paracrine manner to regulate Wnt7b expression. 
Shh and BMP-4 are well established as critical epithelial-mesenchymal regulators 
of SM development at the lung bud tip during branching morphogenesis
80, 93, 95, 159
. In situ 
hybridization (Figure 2.8E, F) and quantitative PCR (Figure 2.8K) on E11.5 Wnt2
-/-
 null 
lung buds indicates that Shh expression levels are similar to wild-type expression levels 
in the primitive lung endoderm. The expression levels of Bmp4 expression levels are also 
comparable between wild-type and Wnt2
-/-
 null lung buds as assessed by in situ 
hybridization (Figure 2.8G, H), and quantitative PCR (Figure 2.8L).  
Shh signals from the lung epithelium to its cognate receptor Patched2 (Ptc2), 
which is expressed in the mesenchyme
93
. Interestingly, quantitative PCR demonstrates 
that in E11.5 Wnt2
-/-
 null lung buds, Ptc2 expression is significantly reduced (Figure 
2.8M). These data indicate that Wnt2 signaling is directly or indirectly regulating the 
responsiveness of the mesenchyme to Shh signaling, which could lead to SM 
differentiation defects
182
.  
 
FGF signaling in Wnt2
-/-
 null lungs 
 FGF signaling is another pathway critical for proper lung SM development
183
.  In 
situ hybridization shows reduced Fgf10 expression in the primitive lung mesenchyme of 
Wnt2
-/-
 null mutant foreguts at E10.5 (Figure 2.8C, D). Quantitative PCR performed on 
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E11.5 lung buds also indicates that Fgf10 expression levels are approximately fifty 
percent lower in Wnt2
-/-
 null lung buds than expression levels in wild-type lung buds 
(Figure 2.8J). These data suggest that Wnt2 signaling is upstream of Fgf10 expression in 
the primitive lung mesenchyme, and the absence of Wnt2 signaling leads to a significant 
loss in Fgf10 expression that impairs development of SMCs into ASM. 
 
FGF-10 signaling regulates smooth muscle gene expression in the lung 
 Genetic models strongly suggest that FGF-10 signaling is necessary for ASM 
development in the lung
125, 183
. To test whether FGF-10 signaling acts upstream of Wnt2 
expression, E11.5 wild-type lung bud explants were treated with either control PBS or 
rFgf10. Expression of Wnt2 was analyzed by quantitative PCR in rFGF-10-treated 
explants to ascertain whether FGF-10 signaling also modulates Wnt2 signaling (Figure 
2.9A). Interestingly, Wnt2 gene expression levels are unaffected by exogenous rFGF-10, 
suggesting that FGF-10 signaling neither activates nor inhibits Wnt2 signaling in a 
feedback loop.  
Treatment of lung explants with rFGF-10 results in a significant upregulation of 
several mature SM markers including SM22", SMA, and Pdgfr" (Figure 2.9A). The 
upregulation in SM gene expression is also evident in histological sections of rFGF-10-
treated wild-type explants. SM22" immunostaining shows an increased layer of staining 
in the developing ASM layer compared to untreated explants (Figure 2.9B, C).  
The expression levels of a few SM genes were not affected by treatment with 
rFGF-10, including MRTFB and myocardin (Figure 2.9A). This could suggest that FGF-
10 signaling promotes SMC development by enhancing the transcriptional activity of the 
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myocardin/MRTFB/SRF co-factors, rather than by upregulating myocardin and MRTFB 
expression. Interestingly, Pdgfr! expression levels were unchanged in the presence of 
rFGF-10. In mature SM of the embryonic lung, Pdgfr! is highly expressed in the 
VSM
169
, and Fgf10-expressing cells are not reported contribute to the VSM
125
. The 
increase in Pdgfr" expression in parallel with the lack of Pdgfr! upregulation in rFGF-
10-treated lung explants is intriguing, and could reflect differential upregulation of genes 
that promote differentiation of immature SMCs into ASM cell populations versus VSM 
cell populations.  
 
Wnt2 regulates smooth muscle development through activation of downstream 
FGF-10 signaling  
The data thus far suggest that Wnt2 signaling mediates ASM development in part, 
through downstream activation of FGF-10 signaling. To further investigate the 
relationship between Wnt2 and FGF-10 signaling, lung buds were dissected from Wnt2
+/- 
heterozygous mutant crosses for lung explant rescue assays with rFGF-10 to determine if 
activated FGF-10 signaling can rescue Wnt2 loss-of-function. Lung bud explants were 
individually cultured in the presence of either control PBS or rFGF-10 for 48 hours, and 
subsequently harvested for histological sectioning and quantitative PCR.  
Quantitative PCR assessment of SM gene expression in control Wnt2
-/- 
null lung 
bud explants treated with PBS reiterates previous results showing decreased expression 
of SM genes including SM22", SMA, myocardin, and Pdgfr" (Figure 2.10A). In the 
presence of rFGF-10, there is partial rescue of SM gene expression levels. Compared to 
untreated Wnt2
-/- 
null lung bud explants, rFGF-10-treated Wnt2
-/- 
null lung bud explants 
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exhibit significant upregulation of SM22" and SMA expression. Myocardin and Pdgfr" 
expression show gross upregulation in rFGF-10-treated Wnt2
-/- 
null lung bud explants, 
however the changes are not statistically significant compared to untreated Wnt2
-/- 
lung 
bud explants. SM22" immunostaining on histological cross-sections shows reduced 
 expression around the developing airways in Wnt2-/- null lung bud explants as expected 
(Figure 2.10C). In the presence of rFGF-10, SM22" expression is increased and is 
localized around the airways in Wnt2
-/- 
null lung bud explants as in wild-type explants 
(Figure 2.10B, D). Overall, these data suggest that rFGF-10 can promote the expansion 
and differentiation of a reduced immature SMC population in Wnt2
-/- 
null lung bud 
explants. The upregulation of several SM genes in the presence of rFgf10 is not 
statistically significant enough to deem a full rescue. However, there is an overall trend 
towards upregulated SM gene expression and the histological data also support a partial 
rescue of the Wnt2
-/- 
loss-of-function ASM phenotype. 
 Taken together, these data suggest a model in which a Wnt2-FGF-10 signaling 
axis regulates the proliferation and differentiation of ASM from primitive mesenchymal 
cells in the lung (Figure 2.11). Wnt2 signaling promotes the differentiation of an 
immature pool of SMCs through direct or indirect activation of a myogenic regulatory 
network including myocardin, SM22", and MRTFB. Wnt2 also activates FGF-10 
signaling in the mesenchyme, which further drives proliferation and mediates continued 
SMC differentiation into mature ASM expressing SM22", SMA, and Pdgfr".  
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Discussion   
 
Recent genetic evidence demonstrates that Wnt/!-catenin signaling lies upstream 
of signals governing SM development in the mouse lung. Loss of the canonical ligand 
Wnt7b in the embryonic lung epithelium leads to severe VSM defects, demonstrating a 
critical role for paracrine Wnt/!-catenin signaling between the developing epithelium and 
mesenchyme
134
. Additional studies demonstrate that genetic deletion of !-catenin in the 
primitive lung mesenchyme also disrupts ASM development
136
, implicating a potential 
function for other canonical Wnt ligands expressed in the lung signaling in mesenchymal 
cells to give rise to ASM. In this study, I identify Wnt2 as a canonical Wnt ligand 
required in the lung mesenchyme to mediate ASM development. This study provides the 
first evidence of a role for Wnt2 signaling in lung SM development. 
 One of the striking aspects of our Wnt2
-/-
 null mutant phenotype is the appearance 
of a hypoplastic lung, which is evident from early stages of lung bud outgrowth through 
perinatal timepoints. One contributing factor to this hypoplasia is the reduction in 
proliferation in both the epithelial and mesenchymal compartment, suggesting that Wnt2 
is signaling in both an autocrine and paracrine manner to regulate the development of 
both tissue compartments. This observation agrees with the well-established role for 
Wnts in tissue growth and a previously described role for Wnt signaling in early lung 
development regulating overall proliferation
139
. Interestingly, proximal-distal patterning 
of the epithelium is unaltered in Wnt2
-/-
 null mutants, suggesting that Wnt2 paracrine 
signaling does not regulate epithelial cell identity.   
Canonical Wnt/!-catenin signaling is active during early lung development
184
, 
and the data presented here demonstrate that Wnt2 signals canonically through !-catenin 
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in the lung. This is supported by the finding of reduced Wnt/!-catenin activity in the 
developing ASM of Wnt2
-/-
 null mutants. However this does not rule out the loss of 
Wnt/!-catenin activity in other cells types that are not resolved in the BAT-GAL 
transgenic model.  
Interestingly, defects in ASM are observed Wnt2
-/-
 null mutants, whereas the 
VSM appears grossly normal. Wnt7b signaling from the lung epithelium regulates VSM 
development
134
, and analysis of Wnt2
-/- 
null mutant lungs demonstrates that Wnt7b is 
expressed in Wnt2
-/-
 null mutants, albeit at reduced levels. Additionally, Wnt2 expression 
is reduced in Wnt7b
-/- 
null lungs (E. Cohen, personal communication), suggesting there is 
signaling interplay between epithelial- and mesenchymal-expressed Wnt ligands in the 
lung. If Wnt2 signaling is important for VSM development, the potential effects from 
loss of Wnt2 signaling may be compensated by the presence of Wnt7b signaling. 
Furthermore, the additional Wnt2-family member, Wnt2b, is also expressed in the lung 
mesenchyme and could function redundantly with Wnt2 signaling (see Chapter 3)
143
.  
A recent study describing conditional mutants in !-catenin signaling in the 
developing lung mesenchyme also suggests a role for Wnt/!-catenin in the differentiation 
of the endothelial lineage
136
, and Wnt2
-/-
 null embryoid bodies are unable to differentiate 
into endothelial cells
142
. In contrast to the published data, the current evidence does not 
indicate a significant defect in endothelial development in Wnt2
-/-
 null lungs. Despite 
slight reductions in the early gene expression of select endothelial and lymphatic 
markers, perinatally, the vasculature and lymphatic vessels appear histologically normal. 
This does not, however, obviate persistent molecular deficiencies in the development of 
these tissues that could affect the physiology and respiration of the neonate. The lack of a 
 
 
50 
prominent embryonic phenotype could be due to compensation by other Wnt ligands 
including Wnt2b and Wnt7b, or other factors signaling through !-catenin to regulate 
endothelial development. Additional studies will be undertaken to address whether there 
are any disruptions in endothelial and development throughout the course of embryonic 
lung development. The significant reduction in VegfC expression hints at possible 
lymphatic defects
185
, suggesting that further analysis of lymphatic markers including 
LYVE-1
186
 and Prox1
187
 is warranted.  
 Wnt2 is expressed during the earliest stages of lung morphogenesis, and therefore 
the perinatal ASM deficiency could be the result of an early defect in the development of 
SMCs in the distal mesenchyme. Analysis of Wnt2
-/-
 null mutants during the early stages 
of myogenesis indicates reduced expression of the genes regulating the earliest aspects of 
SMC differentiation from the primitive mesenchyme including myocardin, MRTFB, and 
Pdgfr!. These results suggest that Wnt2 signaling is regulating the development of the 
multipotent mesenchymal compartment and differentiation of immature SMCs in the 
mouse lung.  
The reduced Pdgfr! expression might be affecting the development of immature 
SMCs that give rise to the VSM, however the VSM appears histologically normal in 
Wnt2
-/-
 null lungs. Wnt7b paracrine signaling also regulates SMC development in the 
primitive mesenchyme, and loss of Wnt7b function decreases the expression of Pdgfr" 
and Pdgfr!22. Yet perinatally, Wnt7b-/- mutants display VSM defects134, a cell lineage 
predominantly expressing Pdgfr!170. Interestingly, the data presented here show that 
activation of FGF-10 signaling — a pathway regulating ASM development —leads to the 
upregulation of Pdgfr" expression, and not Pdgfr! expression. Additional analyses will 
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need to be undertaken to better understand whether there are differences in expression 
levels between Pdgfr" and Pdgfr! in Wnt2-/- null mutants at discrete embryonic 
timepoints. The embryonic origins of ASM and VSM are unclear, and currently there are 
no known genes expressed preferentially in ASM or VSM progenitor populations. The 
disparate SM phenotypes between Wnt7b
-/- 
null mutants and Wnt2
-/-
 null mutants may 
suggest that these signaling pathways are acting on two distinct, as-of-yet described 
immature SMC subpopulations, or it may suggest differential downstream signaling 
effects (e.g. activation of FGF-10) from Wnt ligands that are expressed from different 
tissue compartments.  
A Wnt-FGF regulatory network is thought to govern development of the lung 
mesenchyme
117
, and mice carrying hypomorphic or null alleles of Fgf10 and Fgfr2, the 
cognate receptor of FGF-10, exhibit ASM deficiencies
183, 188
. In Wnt2
-/- 
null mutant lungs, 
both Fgf10 expression and Fgfr2 expression are reduced, implicating a Wnt2-FGF-10 
signaling network in the coordination of ASM development. Using a lung explant assay, I 
demonstrate that FGF-10 signaling promotes ASM development through upregulation of 
several mature SM markers. These findings would suggest that FGF-10 signaling 
mediates the expansion and differentiation of immature SMCs towards a more mature 
ASM lineage.  
The upstream signals governing Fgf10 expression are poorly understood. 
Recently published data from our laboratory examining !-catenin mutant hearts 
demonstrate that Wnt/!-catenin signaling regulates Fgf10 expression in the developing 
cardiac mesoderm
189
. Furthermore, during late stages of lung development, Fgf10 
expression is regulated by Wnt5a
98
. In wild-type lung bud explants treated with rWnt2, 
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Fgf10 expression is significantly upregulated, suggesting that FGF-10 signaling is 
downstream of Wnt2 signaling. However, ectopic FGF-10 expression in lung bud 
explants does not alter Wnt2 expression, suggesting there is no feedback signaling 
occurring between FGF-10 and Wnt2. 
Wnt2 may be regulating FGF-10 signaling directly or indirectly in the lung 
mesenchyme. ASM development relies upon signaling interactions between FGF-10 in 
the mesenchyme and Shh in the epithelium
94
. Loss of Shh expression in the lung 
endoderm, however, does not lead to reduction in Fgf10 expression
71
, suggesting that 
other factors expressed in the mesenchyme are regulating FGF-10 signaling. One possible 
factor that may regulate Fgf10 expression in the lung could be Ptc2, a mesenchymal Shh 
target. In Wnt2
-/-
 null lungs, there is a significant decrease in Ptc2 expression, indicating a 
reduced responsiveness of the lung mesenchyme to pro-myogenic signaling.  
In summary, the studies I have described demonstrate that Wnt2 signaling is 
necessary for ASM development in the mouse lung. Wnt2 expression during early lung 
morphogenesis directs the proliferation and differentiation of ASM from the primitive 
lung mesenchyme. Wnt2 signaling coordinates ASM development through direct or 
indirect upregulation of several well-established myogenic transcription factors and FGF-
10 signaling, which promotes further commitment of immature SMCs towards the ASM 
lineage. In the absence of Wnt2 signaling, ectopic FGF-10 can partially rescue ASM 
development. These results define a Wnt2-FGF-10 signaling axis governing early ASM 
development in the lung.  
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Materials and Methods 
 
Mice 
 Wnt2 mutant mice were generated using recombineering techniques to replace a 
portion of the coding region of the first exon with the reverse tet-activator cDNA (rtta). 
Correctly targeted ES cells were used to generate chimeric mice that were bred to 
transmit these mutant alleles through the germline. Generation and genotyping of the 
BAT-GAL mouse line has been previously described
113
. The University of Pennsylvania 
Institutional Animal Care and Use Committee approved all animal protocols. Genotyping 
primer sequences for the Wnt2 mice are as follows: 
Wnt2
rtta
: 
Wnt2Forward (5’ TGAGTCTCACCACTAGCCGCA 3’) 
Wnt2Reverse (5’ ACTGGGAATCAGCCAGGGAGGGT 3’) 
Wnt2rttaReverse (5’ TCTCAATGGCTAAGGCGTCG 3’) 
Histology  
Embryos were fixed in 4% paraformaldehyde for 24 hours, dehydrated in a series of 
ethanol washes, and then embedded in paraffin for tissue sectioning. Dissected 
embryonic lung buds and foreguts were fixed in 4% paraformaldehyde overnight, 
dehydrated in a series of methanol washes and blocked a 10% normal goat serum/PBS 
solution before wholemount immunostaining. Radioactive in situ hybridization and 
immunohistochemistry were performed as previously described
190
. Tissue sections were 
stained with the following antibodies and dilutions: anti-Axin2 (1:100), anti-CC10 (Santa 
Cruz; 1:20), anti-E Cadherin (Sigma, 1:50), anti-Ki67 (Vector Laboratories, 1:50), anti-
Pdgfr! (Cell Signaling Technology Inc.; 1:50), anti-PECAM (PharMingen; 1:500), anti-
SPC (Chemicon; 1:500), and anti-SM22" (Abcam; 1:500). Quantification of Ki67 
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positive cell populations was performed by using at least three different tissue sections 
from at least three different embryos of the same genotype. !-galactosidase histochemical 
staining of embryos was performed as previously described by our laboratory
134
.  
Quantitative RT-PCR 
Total RNA was isolated from lung tissue at the indicated time points using Trizol 
reagent, reverse transcribed using SuperScript First Strand Synthesis System (Invitrogen), 
and used in quantitative real time PCR analysis using the oligonucleotides listed below. 
RNA was isolated from at least 5 lung bud tissue samples corresponding to each 
genotype. 
Axin2 
F (5’ CAGCCCTTGTGGTTCAACCT 3’) 
R (5’ GGTAGATTCCTGATGGCCGTAGT 3’) 
Bmp4 
F (5’ CCCTTTCCACTGGCTGATCA 3’) 
R (5’ GGGACACAACAGGCCTTAGG 3’) 
CC10 
F (5’ ATCCTAACAAGTCCTCTGTGTAAGCA 3’) 
R (5’ GGAGACACAGGGCAGTGACA 3’) 
Cyclin D1 
F (5’ GATGTGAGGGAAGAGGTGAAGGT 3’) 
R (5’ CAATGAGAATCTGGTTCTGAACGT 3’) 
Fgf9 
F (5’ TTCATGCGGTGGGTTCTTATT 3’) 
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R (5’ TCCTCATCCAAGCTTCCATCA 3’) 
Fgf10 
F (5’ CAGTAAGACACGCAAGCATTTACTG 3’) 
R (5’AATCTGATCCAATTCTTCCATGGT 3’) 
Fgfr2 
F (5’ GCTTCTCAGTGAGTTTTAATAACAGCTT 3’) 
R (5’ GAATGATGCTGGGCTTTTGC 3’) 
Flk1 
F (5’ AGAGCGATGTGTGGTCTTTCG 3’) 
R (5’ TCTCCTACAAAATTCTTCATCAATCTTG 3’) 
MRTFB 
F (5’ CAACATGGAGTGGCTAGACATTACC 3’) 
R (5’ GGTCCAGAAAATCAGCAGAGAAC 3’) 
Myocardin 
F (5’ CAACACCTTGCCCAGTTATCAG 3’) 
R (5’ GCAGCGGACAAGTCAGATGA 3’) 
Nkx2.1 
F (5’ CTTCATCTTTCCCCCCTTCCT 3’) 
R (5’ GGTTGAATTTGCTTGGCTGTTT 3’) 
N-myc 
F (5’ TGTGTTGACATTAAGAATGTTGGTTTAC 3’) 
R (5’ TTTCCAAGGTCATGGCAGAAC 3’) 
Pdgfr" 
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F (5’ TGCAGTTGCCTTACGACTCCAGAT 3’) 
R (5’ AGCCACCTTCATTACAGGTTGGGA 3’) 
Pdgfr! 
F (5’ ACTACATCTCCAAAGGCAGCACCT 3’) 
R (5’ TGTAGAACTGGTCGTTCATGGGCA 3’) 
Pecam1 
F (5’ ATTCCTCAGGCTCGGGTCTT 3’) 
R (5’ CATGCACCTTCACCTCGTA 3’) 
Ptc2 
F (5’ AACATGGTCGCCTTTTTCATG 3’) 
R (5’ GCATTACCGCTGCAAAGTTG 3’) 
Shh 
F (5’ ACCCAACTCCGATGTGTTCCGTTA 3’) 
R (5’ TATATAACCTTGCCTGCCGCTGCT 3’) 
rSMA (these sequences are based on rat sequence, but cross-react with mouse transcripts) 
F (5’ GCTCCTCCAGAACGCAAATATT 3’) 
R (5’ TCGTCATACTCCTGTTTGCTGATC 3’) 
SP-C 
F (5’ CCCTCCACACCCACCTCTAA 3’) 
R (5’ CACAGCAAGGCCTAGGAAAGC 3’) 
VegfA 
F (5’ GTACCTCCACCATGCCAAGTG 3’) 
R (5’ AGCTTCGCTGGTAGACATCCA 3’) 
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VegfC 
F (5’ AGAAGACCGTGTGCGAATCG 3’) 
R (5’ AGATGTGGCCTTTTCCAATACG 3’) 
VegfD 
F (5’ CAGGAGAACCCTTGATTCAACTTC 3’) 
R (5’ GGGTAGTGGGCAACAGTGACA 3’) 
Wnt2 
F (5’ TCTTGAAACAAGAATGCAAGTGTCA 3’) 
R (5’ GAGATAGTCGCCTGTTTTCCTGAA 3’) 
Wnt7b 
F (5’ GGATGCCCGTGAGATCAAAA 3’) 
R (5’ CACACCGTGACACTTACATTCCA 3’) 
Lung explant cultures 
Lung buds were dissected from E11.5 embryos and cultured in BGjb media (Invitrogen) 
supplemented with .1mg/ml ascorbic acid and anti/anti for 48 hours as previously 
described
104
. Explants were cultured on a .4µm membrane filter (BD Falcon). Embryos 
were collected from wild-type females or generated from Wnt2 heterozygous mutant 
crosses. Exogenous recombinant human Wnt2 protein (Novus Biologicals) was added to 
the lung explant media at a concentration of .15ug/ml. Exogenous recombinant human 
Fgf10 (R & D Systems) was added to the lung explant media at a concentration of 
200ug/ml. At least 8 explants were used for each experimental condition and treatment. 
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Cell Culture 
10T1/2 cells were cultured in Eagle's Basal medium with Earle's BSS, 2 mM L-
glutamine, 1.5 g/L sodium bicarbonate, and 10% heat-inactivated fetal bovine serum as 
suggested by ATCC. Recombinant human Wnt2 protein was added to the 10T1/2 media 
at a concentration of .15ug/ml, and cultured for 48 hours before harvesting for Q-PCR 
analysis.  
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Table 2.1:  Survival ratios of Wnt2 mutants. 
 
Genotypes of offspring from crosses between Wnt2
+/-
 heterozygous mice (expect 1:2:1 
ratio of Wnt2
+/+
: Wnt2
+/-
: Wnt2
-/-
). 
 
Genotype E12.5-E14.5 E18.5 3 weeks 
+/+ 23 (25%) 18 (24%) 53 (30.5%) 
+/- 48 (52%) 41 (54%) 114 (66%) 
-/- 21 (23%) 17 (22%) 7 (4%) 
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Figure 2.1: Expression pattern of Wnt2 during lung development. 
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Figure 2.1. Expression pattern of Wnt2 during lung development.   
(A-F) In situ hybridization for Wnt2 expression on wild-type embryo cross-sections. (A, 
B) Wnt2 is expressed in the splanchnic mesoderm surrounding the ventral aspect of the 
anterior foregut from E9.0-E9.5. (C-F) From E12.5-E18.5, Wnt2 is expressed in the 
developing mesenchyme with higher levels surrounding the distal regions of the 
branching airways. Scale bars=200 µm (A, B), 600 µm (C, D, E), 800 µm (F).  
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Figure 2.2: Wnt2 gene targeting strategy. 
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Figure 2.2: Wnt2 gene targeting strategy. 
(A) Schematic of the Wnt2 gene targeting strategy with a representative Southern blot 
using the indicated probe1/ HindIII and probe 2/BamHI digests (B). The reverse tet-
activator (rtta) cDNA was used to replace the coding region of exon 1 of Wnt2. The 
neomycin cassette was removed using Flper mice (flp sites=green circles). (C) PCR was 
used to verify its loss (+/neo=Wnt2
+/-
 with neo cassette, +/#neo=Wnt2
+/-
 without neo 
cassette, neo/neo=Wnt2
-/- 
with neo cassette, +/+=wild type littermate, - = water PCR 
control). For unknown reasons, the rtta is not active in this animal model.  
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Figure 2.3: Loss of Wnt2 leads to lung hypoplasia and down-regulation of pathways  
 
required for lung development. 
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Figure 2.3: Loss of Wnt2 leads to lung hypoplasia and down-regulation of pathways  
 
required for lung development.   
 
Wnt2
-/-
 null mutants exhibit lung hypoplasia as shown by whole mount comparison (A, 
B) and H+E staining of histological cross-sections from E14.5 and E18.5 Wnt2
-/-
 null 
embryos (C-H) and P0 lungs (I, J).  Dilation of alveolar sacs and thinned mesenchyme is 
observed at E18.5 (G, H) and at P0 (I, J) in Wnt2
-/-
 null lungs. (K-N) Whole mount 
immunostaining of E14.5 lung buds with E-cadherin shows relatively normal distal 
branching of airways in Wnt2
-/-
 null lungs (M, N). Ki67 immunostaining indicates a 
significant decrease in proliferation in both the lung endoderm and mesenchyme of  
Wnt2
-/-
 null mutants (O, P), and this is confirmed by quantification of proliferation in 
both compartments (Q). (R) Quantitative PCR on E11.5 Wnt2
-/-
 null lungs indicates 
decreased expression of genes critical for lung development. (S-V) Normal proximal-
distal patterning occurs in Wnt2
-/-
 null lungs as assessed by SP-C (S, T) and CC10 (U, V) 
immunostaining. Error bars indicate one standard deviation. Airways denoted by ($) 
symbol on histological sections. Scale bars=800 µm (C, D, E, F), 200 µm (G, H, S, T), 
400 µm (U, V), 600 µm (I, J), 100 µm (O, P). 
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Figure 2.4: Wnt2
-/-
 null lungs exhibit airway smooth muscle defects. 
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Figure 2.4: Wnt2
-/-
 null lungs exhibit airway smooth muscle defects. 
Histological cross-sections of E18.5 wildtype (A, C) and Wnt2
-/-
 null mutant embryos (B, 
D). (A-D) SM22" immunostaining demonstrates reduced SM around the distal airways 
(B, arrowheads) in Wnt2
-/-
 null lungs. Higher magnification (C, D) reveals the lack of a 
contiguous layer of SM surrounding the airway epithelium in Wnt2
-/-
 null lungs (D, 
arrowheads). The SM layer surrounding adjacent blood vessels does not appear to be 
reduced (arrows in A, B). (E, F) Histological cross-sections of lacZ-stained E14.5 wild-
type BAT-GAL and Wnt2
-/-
:BAT-GAL mutant embryos shows lacZ expression in wild-
type epithelium (E, arrows) and primitive ASM cells (E, arrowheads). Loss of Wnt2 in 
the BAT-GAL background results in decreased lacZ expression in SMCs (F, arrowhead), 
while epithelial lacZ expression is retained (F, arrows). (G, H) Axin2 immunostaining on 
E14.5 wild-type lung cross-sections demonstrates robust expression in the developing 
ASM (G, arrowhead), and this expression is reduced in Wnt2
-/-
 null mutant lungs (H, 
arrowhead). Airways denoted by ($) symbol on histological sections. Scale bars=200 µm 
(A, B, E, F), 100 µm (C, D, G, H).  
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Figure 2.5: Loss of Wnt2 disrupts development of the lung mesenchyme and  
 
immature smooth muscle. 
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Figure 2.5: Loss of Wnt2 disrupts development of the lung mesenchyme and 
immature smooth muscle. 
Histological cross-sections of E11.5 and E14.5 wild-type (A, C, E, G) and Wnt2
-/- 
null 
mutant embryos (B, D, F, H). (A, B) At E11.5, SM22" immunostaining demonstrates 
expression in the primitive ASM layer (A, arrowhead), and this expression is reduced in 
Wnt2
-/-
 null lungs (B, arrowhead). (C, D) PDGFR! immunostaining shows expression 
throughout the lung mesenchyme in E11.5 wild-type lung tissue (C), however this 
mesenchymal expression is reduced in Wnt2
-/- 
null lungs (D). (E-H) In situ hybridizations 
for myocardin show decreased expression in the developing SM surrounding the airways 
at E11.5 (arrowheads in E, F) and later at E14.5 (arrowheads in G, H). (I-L) Assessment 
of mesenchymal and immature smooth muscle gene expression by quantitative PCR on 
E11.5 lung buds demonstrates significantly reduced levels of myocardin, MRTFB, 
Pdgfr!, and SM22" expression in Wnt2-/- null lung buds. Error bars indicate one standard 
deviation. *P < 0.05. N=5 lung buds. Airways denoted by ($) symbol on histological 
sections. Scale bars=200 µm (A-F), 400 µm (G, H). 
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Figure 2.6: Wnt2 signaling is sufficient to promote smooth muscle development in  
 
mesenchymal cell types. 
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Figure 2.6: Wnt2 signaling is sufficient to promote smooth muscle development in 
mesenchymal cell types. 
Assessment of SM gene expression by quantitative PCR in 10T1/2 cells (A) and wild-
type E11.5 lung bud explants (B) cultured in the absence (control) or presence of rWnt2 
protein. (A) Treating immortalized multipotent fibroblast-like 10T1/2 cells for 48 hours 
with rWnt2 leads to increased expression of SM genes including SM22", SMA, 
myocardin, Pdgfr", Pdgfr!, and Fgf10. Treatment of wild-type lung bud explants with 
rWnt2 also leads to increased SM gene expression (B). (C, D) SM22" immunostaining 
on histological cross-sections of the cultured lung bud explants shows increased 
expression in the developing ASM in the presence of rWnt2 (D). Error bars indicate one 
standard deviation. *P < 0.05. N=5 lung bud explants. Scale bars=200 µm (C, D). 
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Figure 2.7: Development of other mesenchymal-derived lineages in Wnt2
-/- 
null  
 
lungs. 
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Figure 2.7: Development of other mesenchymal-derived lineages in Wnt2
-/- 
null 
lungs. 
Histological cross-sections of E18.5 wild-type (A) and Wnt2
-/-
 null mutant embryos (B). 
PECAM immunostaining shows no change in expression levels between wild-type (A) 
and Wnt2
-/-
 null lung tissue (B). (C-E) Quantitative PCR on E12.5 lung bud tissue shows 
no significant changes in expression levels of Pecam1 (C) and Flk1 (D) between wild-
type and Wnt2
-/-
 null mutant lung buds. (E) Analysis of Vegf family members expressed 
in the lung indicates that VegfC expression is significantly reduced in Wnt2
-/-
 null mutant 
lung buds. Error bars indicate one standard deviation. *P < 0.05. N=5 lung buds. Airways 
denoted by ($) symbol on histological sections. Scale bars=600 µm (A, B). 
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Figure 2.8: Evaluation of signaling factors important for smooth muscle  
 
development in Wnt2
-/-
 null lungs. 
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Figure 2.8: Evaluation of signaling factors important for smooth muscle 
development in Wnt2
-/-
 null lungs. 
Histological cross-sections of wild-type (A, C, E, G) and Wnt2
-/- 
null mutant embryos (B, 
D, F, H). (A, B) At E10.5, in situ hybridization for Wnt7b shows reduced expression in 
the primitive lung endoderm of Wnt2
-/- 
null tissue. (C, D) In the adjacent mesenchyme, in 
situ hybridization shows that Fgf10 expression is also reduced in E10.5 Wnt2
-/- 
null 
mutant tissue. (E, F) At E11.5, in situ hybridization for Shh shows similar levels of 
expression in the primitive lung epithelium of wild-type and Wnt2
-/- 
null tissue. (G, H) At 
E11.5, in situ hybridizations indicate no changes in Bmp4 expression levels in the lung 
mesenchyme and epithelium between wild-type and Wnt2
-/-
 null mutant tissue. (I-M) 
Assessment by quantitative PCR on E11.5 lung buds demonstrates that Wnt7b (I), Fgf10 
(J), and Ptc2 (M) expression levels are significantly reduced in Wnt2
-/-
 null lung buds, 
whereas the expression levels of Shh (K) and Bmp4 (L) are unchanged. Error bars 
indicate one standard deviation. *P < 0.05. N=5 lung buds. Primitive airway denoted by 
($) symbol on histological sections. Scale bars=100 µm (A-H). 
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Figure 2.9: FGF-10 signaling regulates smooth muscle gene expression and  
 
development in lung buds.   
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Figure 2.9: FGF-10 signaling regulates smooth muscle gene expression and 
development in lung buds.   
(A) Assessment of SM gene expression by quantitative PCR in wild-type lung bud 
explants treated with either PBS (control) or rFGF-10. Treating wild-type lung bud 
explants with rFGF-10 leads to increased expression of SM genes including SM22", 
SMA, and Pdgfr". (B, C) SM22" immunostaining on histological cross-sections of lung 
bud explants treated with rFGF-10 shows increased expression in the developing SM 
around primitive airways (C). Error bars indicate one standard deviation. *P < 0.05. N=5 
lung bud explants. Scale bars=100 µm (B, C). 
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Figure 2.10: Wnt2 regulates smooth muscle development through activation of  
 
downstream FGF-10 signaling. 
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Figure 2.10: Wnt2 regulates smooth muscle development through activation of 
downstream FGF-10 signaling. 
(A) Assessment of SM gene expression by quantitative PCR in cultured E11.5 Wnt2
+/+
 
wildtype and Wnt2
-/-
 null lung bud explants. In the presence of rFGF-10, the expression 
levels of SM22" and SMA are significantly upregulated compared to untreated Wnt2-/- 
null lung bud explants. The expression levels of myocardin and Pdgfr" are increased, 
however the increase is not statistically significant compared to expression levels in 
untreated Wnt2
-/-
 null lung bud explants. Wnt2 expression levels were also measured to 
confirm the genotyping of lung bud explant populations. (B-D) SM22" immunostaining 
on histological cross-sections of control Wnt2
-/-
 null lung bud explants shows reduced 
expression in the primitive ASM (C). In the presence of rFGF-10, there is increased 
SM22" expression in the SM layer surrounding the airways, and this expression pattern 
appears similar to that in Wnt2
+/+
 wildtype lung bud explants (compare B and D). Error 
bar indicates one standard deviation. *P < 0.05. N=8 lung bud explants. Scale bars=100 
µm (B-D). 
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Figure 2.11: Model of Wnt2 signaling in lung airway smooth muscle development. 
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Figure 2.11: Model of Wnt2 signaling in lung airway smooth muscle development. 
Wnt2 signaling in the primitive lung mesenchyme promotes the proliferation and 
differentiation of the PDGFR"/!-expressing multipotent mesenchyme into early-stage 
SMCs in part, by activating a myogenic transcriptional network including myocardin, 
SM22", and MRTFB. Wnt2 signaling also activates FGF-10 signaling, which further 
promotes amplification and differentiation of immature SMCs into an intermediate SMC 
type expressing mature ASM markers including SM22", SMA, and PDGFR".  
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Chapter 3: Wnt2/2b and !-catenin signaling are required for lung organogenesis 
This chapter has been published in Developmental Cell (Goss et al., 2009). 
 
Summary 
In Chapter 1, I gave an overview of mouse endoderm development and how 
progenitor specification within the foregut endoderm precedes organogenesis. However 
the molecular pathways that specify foregut endoderm progenitors in the mouse are 
poorly understood. The Wnt family of ligands comprises plausible candidates for 
mediating mouse foregut endoderm identity because of its prominent role in the 
development of multiple tissue types and spatiotemporal patterns of expression during 
foregut endoderm development. In this chapter, I show that Wnt2/2b signaling is required 
to specify lung endoderm progenitors within the anterior foregut. I also show that this 
phenotype is recapitulated by an endoderm restricted deletion of !-catenin, demonstrating 
that Wnt2/2b signaling through the canonical Wnt pathway is required to specify lung 
endoderm progenitors within the foregut. And finally, I show that activation of canonical 
Wnt/!-catenin signaling results in reprogramming of esophagus and stomach endoderm 
to a lung endoderm progenitor fate. Together, these data reveal that canonical Wnt2/2b 
signaling is uniquely required for specification of lung endoderm progenitors in the 
developing foregut.  
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Introduction 
As mentioned in Chapter 1, the vertebrate gut tube is patterned such that organs 
are specified in a precise spatial location along the anterior-posterior axis of the 
developing embryo. Signaling molecules expressed in the surrounding splanchnic 
mesoderm are thought to promote development and patterning of these organs including 
the thyroid, lung, liver, and pancreas, in part through proper specification of endoderm 
progenitors
42
. Although several important signaling pathways have been implicated in the 
regulation of foregut endoderm development, the pathways that uniquely specify the lung 
within the anterior foregut are unknown.   
Wnt signaling is one such pathway known to be important for early tissue 
morphogenesis. Multiple roles for !-catenin in cell proliferation and differentiation have 
been reported in the endodermal components of several tissues including the liver, 
pancreas, and lung 
191-196
. However, whether Wnt signaling plays a role in the 
specification of foregut derived tissues remains unclear.   
In this chapter, I show that Wnt2 and Wnt2b play an essential and cooperative 
role in specifying lung endoderm progenitors within the anterior foregut without affecting 
the specification of other foregut derived tissues. Moreover, I show that activation of 
Wnt/!-catenin signaling can reprogram posterior endoderm to a lung progenitor fate 
indicating the potent role of Wnt signaling in specifying early lung endoderm 
progenitors. These studies reveal a unique role for Wnt/!-catenin signaling in promoting 
lung endoderm specification in the foregut. 
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Results 
Expression of Wnt2 and Wnt2b during foregut development 
Previous studies have reported the expression of several Wnt ligands in the lung 
including Wnt2, Wnt5a, Wnt7b, and Wnt11 
97, 197
.  Given the importance of the Wnt 
pathway in endoderm development and regulation of tissue specific progenitors, the 
expression pattern of candidate Wnt ligands were explored to determine whether any 
were expressed in the appropriate spatial and temporal pattern to regulate development of 
lung endoderm progenitors in the foregut. The analysis revealed that from E9.0-E10.5, 
Wnt2 and Wnt2b are expressed in a highly restricted domain of the splanchnic mesoderm 
surrounding the ventral aspect of the anterior foregut when the lung is specified (Figure 
2.1A, B; Figure 3.1A, B). The Wnt2 expression pattern was described in Chapter 2 — 
briefly, Wnt2 is expressed in the splanchnic mesoderm at E9.0, and later at E11.5 
throughout the developing lung mesenchyme up through birth
141
. 
The expression of Wnt2b, like Wnt2, is upregulated at E11.5 in the developing 
lung mesenchyme (Figure 3.1C, D), although at lower levels and for a shorter duration 
than Wnt2 (compare Figure 2.1C, D with Figure 3.1C, D). Notably, the expression 
patterns of Wnt2/2b overlap spatially and temporally in the splanchnic mesoderm and 
lung mesenchyme (compare Figure 2.1A, B and Figure 3.1A, B), suggesting that both 
ligands function redundantly in these tissues. The spatial and temporal expression of 
Wnt2/2b in the splanchnic mesoderm also suggests that Wnt2/2b signaling regulates lung 
specification and development.  
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Loss of Wnt2 function leads to lung developmental defects and loss of Wnt2b 
function does not appear to impact lung development 
In Chapter 2, I described investigations examining the role of Wnt2 signaling in 
lung development using a Wnt2 loss-of-function knockout mouse model. Those results 
revealed that loss of Wnt2 function impaired proper lung development and led to 
perinatal mortality. To understand the functions of Wnt2b during lung development, 
Wnt2b
-/-
 null mutant mice were obtained from a collaborating laboratory. These mice 
were generated using homologous recombination to insert loxP sites flanking exons 2 and 
3 at the Wnt2b locus (Figure 3.2). To generate Wnt2b
-/-
 null mutant mice, Wnt2b 
conditional mutant mice were bred to the transgenic CMV-cre mouse line, which 
expresses a tissue wide cre recombinase. Interestingly Wnt2b
-/-
 null mutants are viable 
with no discernable lung phenotype, suggesting that Wnt2 is compensating and 
functioning redundantly with Wnt2b.  
 
The combined loss of Wnt2 and Wnt2b signaling leads to lung agenesis 
To address the combined role of Wnt2/2b signaling in lung development, the 
Wnt2 and Wnt2b knockout mice were interbred to generate Wnt2/2b double knockout 
(DKO) mutants. Histological examination of Wnt2/2b DKO mutants at E14.5 reveals 
complete lung agenesis with no signs of tracheal development (Figure 3.3D-F). In the 
absence of lung tissue, the atria of the developing heart fill the chest cavity. Interestingly, 
other foregut-derived tissues appear unperturbed in Wnt2/2b DKO mutants (Figure 3.3G-
Q). Histological sections indicate the presence of stomach, liver, pancreas, gut, and 
kidneys in Wnt2/2b DKO mutants (Figure 3.3N-Q) that are structurally comparable to 
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their counterparts in wild-type embryos (Figure 3.3J-M). These results demonstrate that 
Wnt2 and Wnt2b signal cooperatively in the splanchnic mesoderm to specifically mediate 
the development of the lung, but not the development of other foregut-derived organs. 
To understand whether an initial lung bud developed in Wnt2/2b DKO mutants, 
embryos were collected at earlier timepoints during lung development. At E11.5, while 
the esophagus and trachea are readily apparent in wild-type embryos (Figure 3.4A-C), 
neither lung nor tracheal development is observed in Wnt2/2b DKO mutants (Figure 
3.4D-F). Additionally, immunostaining of dissected foreguts with a pan-epithelial E-
cadherin antibody three dimensionally resolves the complete lack of tracheal budding in 
Wnt2/2b DKO mutants (Figure 3.4G, H). The whole mount immunostained tissue 
demonstrates that Wnt2/2b DKO mutants possess only a single endoderm tube, with no 
detectable ventral budding from the foregut. 
 
Loss of Wnt2/2b leads to the loss of lung endoderm progenitors 
The absence of tracheal budding suggests that there is a loss of lung progenitors in 
the ventral foregut endoderm of Wnt2/2b DKO mutants. To determine whether the lung 
endoderm lineage is specified in Wnt2/2b DKO mutants, embryos were collected at E9.5 
when the lung primordia is established in the foregut. Histological sections reveal that 
there is no detectable budding of the ventral endoderm in Wnt2/2b DKO mutants (Figure 
3.5A, E). Specification of the lung in the foregut was examined by immunostaining for 
Nkx2.1 expression in Wnt2/2b DKO mutant tissue. Recall from Chapter 1 that Nkx2.1 is 
a transcription factor that is the earliest known marker of the developing lung endoderm, 
and also denotes the thyroid primordia 
77, 198
. Nkx2.1 expression is first observed by 
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immunohistochemistry and in situ hybridization at E9.5 in the ventral aspect of the 
foregut, demarcating where the trachea will bud from the anterior foregut (Figure 3.5B) 
54, 144, 199
. Surprisingly, Nkx2.1 expression is absent in the anterior foregut region of 
Wnt2/2b DKO mutants (Figure 3.5F), confirming the loss of tracheal and lung 
development. Examining for Nkx2.1 expression along the anterior-posterior axis of 
Wnt2/2b DKO mutants demonstrates a specific loss of Nkx2.1 expression at the level of 
the presumptive tracheal bifurcation (Figure 2.3I-P). 
The thyroid primordium, which is anterior to the lung primordium, retains 
expression of Nkx2.1 (Figure 3.5C, G), indicating that Wnt2/2b signaling is not required 
for thyroid specification. The single endoderm tube in Wnt2/2b DKO mutants expresses 
the esophageal epithelial marker p63 (Figure 3.5D, H), demonstrating that the endoderm 
tube retains esophageal identity in the absence of tracheal and lung specification. Overall, 
these results suggest that Wnt2/2b signaling regulates the specification of lung 
progenitors in the foregut endoderm.  
 
Loss of lung progenitors is not due to aberrant cell proliferation or cell death in 
Wnt2/2b DKO mutant foreguts 
The loss of lung progenitors in the foregut endoderm could be attributed to cell 
proliferation defects and/or increased cell apoptosis. Ki67 immunostaining was 
performed in order to analyze the proliferation index of wild-type and Wnt2/2b DKO 
mutant foregut endoderm. Compared to wild-type foregut tissue (Figure 3.6A), there is 
no quantitative difference in proliferation in Wnt2/2b DKO mutants (Figure 3.6B, C). 
Additionally, TUNEL staining demonstrates that there is no increase in apoptosis in 
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Wnt2/2b DKO mutant foreguts over wild-type foreguts (Figure 3.6D, E). Therefore, the 
loss of lung endoderm progenitors in Wnt2/2b DKO mutants is not due to either 
decreased cell proliferation or increased cell death, suggesting that the loss stems directly 
from the absence of a specification event.  
 
Loss of lung gene expression in Wnt2/2b DKO mutants 
Several genes are reported to play critical roles in the development of foregut 
endoderm progenitors, with some specifically regulating lung progenitor development. 
Quantitative PCR on dissected foreguts from E10.5 embryos (Figure 3.6F) confirms the 
loss of Nkx2.1 expression in Wnt2/2b DKO foreguts. The minimal expression of Nkx2.1 
in Wnt2/2b DKO mutant foreguts is likely due to the presence of contaminating thyroid 
cells, which retain Nkx2.1 expression (Figure 3.5G). Foxa2 is a transcription factor 
expressed throughout the foregut endoderm, which contributes to foregut progenitor 
competence
200
. In situ hybridization for Foxa2 reveals expression in the foreguts of wild-
type tissue and Wnt2/2b DKO tissue (Figure 3.6G, H), indicating that foregut endoderm 
identity is not lost in the absence of Wnt2/2b signaling. 
The expression of Wnt7b, an additional marker of early lung endoderm 
progenitors in the anterior foregut 
134
, is also lost in Wnt2/2b DKO mutants. In situ 
hybridization demonstrates an absence of Wnt7b expression in the ventral foregut (Figure 
3.6I, J), and quantitative PCR also confirms this loss (Figure 3.6F). The residual Wnt7b 
expression in the Wnt2/2b DKO foreguts is likely due to other contaminating tissue types 
(e.g. the pancreas primordium)
61
.  
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Wnt2/2b DKO phenotype is distinct from other lung agenesis phenotypes 
The phenotype of Wnt2/2b DKO mutant embryos is not mimetic to other lung 
hypoplasia phenotypes, including the loss of Fgf10 and loss of Gli2/Gli3 expression, in 
that the lung is uniquely affected and specification is completely lost. Fgf10
-/-
 null 
mutants form a trachea which does not branch, indicating that the lung endoderm lineage 
is specified but fails to grow and branch 
68, 70
. Gli2/Gli3 double null mutants fail to form a 
lung, but other aspects of foregut development are severely affected, including the loss of 
the esophagus 
72
. To develop a hierarchical model of lung specification, expression of 
Fgf10, Gli2, and Gli3 was assessed to determine whether their expression was affected by 
the loss of Wnt2/2b signaling.   
In situ hybridization on Wnt2/2b DKO mutant tissue reveals reduced expression 
of Fgf10 (Figure 3.6K, L), suggesting that Fgf10 expression is downstream of Wnt 
signaling in the anterior foregut. Although our laboratory has demonstrated that Fgf10 is 
a direct target of Wnt/!-catenin signaling in cardiac mesoderm 
189
, it remains possible 
that loss of Fgf10 expression is secondary to a loss of lung specification.  In contrast to 
the loss of Fgf10 expression, Gli2 and Gli3 expression were unchanged in the anterior 
foregut region of Wnt2/2b DKO mutants. In situ hybridization shows comparable Gli3 
expression levels between wild-type and Wnt2/2b DKO mutant tissue (Figure 3.6M, N), 
and quantitative PCR indicates no change in Gli2 or Gli3 expression in Wnt2/2b DKO 
mutant foreguts (Figure 3.6F). Together, these data suggest that Wnt2/2b signaling acts 
upstream of Fgf10, but not Gli2/Gli3 in the regulation of lung specification.  
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Wnt2 and Wnt2b signal through the !-catenin-dependent canonical pathway in the 
primitive lung endoderm 
Wnt ligands can signal through several distinct pathways to regulate cell 
specification and tissue development. The best understood of these is the !-catenin 
dependent canonical pathway, which has been demonstrated to regulate development and 
differentiation of several tissues including hair follicles, intestinal epithelium, and the 
heart 
189, 201, 202
. To assess whether the canonical Wnt pathway was affected by the loss of 
Wnt2/2b, we crossed the BAT-GAL canonical Wnt reporter line 
113
 to Wnt2/2b DKO 
mutants and performed lacZ staining in wild-type BAT-GAL embryos, Wnt2
-/-
:BAT-GAL, 
Wnt2b
-/-
:BAT-GAL, and Wnt2/2b:BAT-GAL DKO null mutants.   
LacZ expression from the BAT-GAL Wnt reporter line is reduced in Wnt2
-/-
 null 
mutant foreguts (Figure 3.7A-D), suggesting that Wnt2 signals through !-catenin in the 
foregut endoderm. These data complement the BAT-GAL data presented in Chapter 2 
(Figure 2.4E, F), which demonstrated that Wnt2 signals through !-catenin in the lung 
mesenchyme at later developmental stages. LacZ expression is also reduced in Wnt2b
-/-
 
null mutants (Figure 3.7E), and is absent in the anterior foregut endoderm in Wnt2/2b 
DKO mutants (Figure 3.7F). The loss of !-catenin activity in the foregut endoderm upon 
the combined loss of Wnt2 and Wnt2b suggests that Wnt2/2b signal through !-catenin in 
the foregut. Therefore, these data placed into context with the Wnt2/2b DKO lung 
agenesis phenotype suggest a critical role for !-catenin signaling in mediating lung 
progenitor development in the foregut. 
To further address whether canonical Wnt/!-catenin signaling is necessary in the 
developing foregut endoderm for lung specification, I utilized a commercially available 
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mouse line that expresses cre recombinase throughout the foregut endoderm to modulate 
!-catenin signaling activity. The mouse line harbors a gene encoding a gfp-cre 
recombinase fusion protein, which has been inserted at the Sonic hedgehog (Shh) locus 
through homologous recombination
203
. As a knock-in model, cre recombinase expression 
should faithfully recapitulate the temporospatial dynamics of Shh promoter activity in the 
developing endoderm. To confirm the fidelity of the mouse model as a tool, Shh-cre 
heterozygous mice were bred to the cre-dependent lacZ mouse reporter strain, ROSA26 
204
. Lineage mapping in Shh-cre:R26R embryos demonstrates cre activity in the foregut 
endoderm at E8.75 (Figure 3.7G), just prior to lung specification, and at E9.25 in the 
tracheal bifurcation at the onset of lung specification (Figure 3.7H, I-K). Slightly later at 
E11.5, there is cre activity in the tracheal endoderm that extends throughout the primitive 
endoderm of the lung, stomach, and gut (Figure 3.7L-O).  
 
!-catenin signaling is necessary for lung progenitor specification in the foregut 
endoderm 
To test whether !-catenin signaling activity contributes to lung progenitor 
development, the !-catenin gene (Ctnnb1) was genetically deleted using the Shh-cre 
mouse line in conjunction with a mouse line carrying conditional alleles of !-catenin205. 
Immunostaining for !-catenin protein expression demonstrates !-catenin gene excision 
as denoted by the absence of !-catenin protein in E9.5 Ctnnb1
flox/flox
:Shh-cre mutant 
foreguts (Figure 3.8I, J). Interestingly, Ctnnb1
flox/flox
:Shh-cre mutants exhibit a 
histological phenotype identical to Wnt2/2b DKO mutants. Histological sections 
demonstrate a complete lack of tracheal budding in Ctnnb1
flox/flox
:Shh-cre mutants (Figure 
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3.8E-G). Whole mount E-cadherin immunostaining confirms the loss of tracheal and lung 
bud formation in Ctnnb1
flox/flox
:Shh-cre mutants (Figure 3.8O, P).  
Additionally, there is a complete loss of Nkx2.1 expression in the ventral foregut 
at the site of the presumptive tracheal bifurcation (Figure 3.8H). However, specification 
of other gut-derived tissues including the esophagus and thyroid is unaffected (Figure 
3.8M, N). Immunostaining for p63 expression indicates that the single endoderm tube in 
Ctnnb1
flox/flox
:Shh-cre mutants retains esophageal identity (Figure 3.8K, L). Overall, these 
data demonstrate that !-catenin signaling in the foregut endoderm is required to specify 
lung endoderm progenitors. 
 
Activation of Wnt/!-catenin signaling leads to reprogramming of the posterior 
foregut endoderm to a lung endoderm fate 
The potent role for Wnt/!-catenin signaling in specifying lung endoderm 
progenitors suggested that ectopic activation of this pathway might promote expansion of 
lung endoderm progenitor identity outside the normal region in the foregut. To test this 
hypothesis, the Shh-cre mouse line was crossed with the Ctnnb1
(ex3)flox
 mouse line to 
generate Ctnnb1
(ex3)flox
:Shh-cre mutants. These mutants will express the stabilized form of 
!-catenin lacking the phosphorylation sites required for !-catenin degradation, thereby 
leading to strong activation of Wnt/!-catenin signaling 
206
. At E10.5, Ctnnb1
(ex3)flox
:Shh-
cre mutants display defects in tracheal-esophageal septation (Figure 3.9E, F), and 
immunostaining reveals expansion of Nkx2.1 positive lung progenitors into the hindgut 
region, corresponding to the primitive stomach endoderm (Figure 3.9H).  This expansion 
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is also evident at E11.5 in Ctnnb1
(ex3)flox
:Shh-cre mutants, where the esophagus and 
proximal stomach are populated with Nkx2.1 positive lung progenitors (Figure 3.9O, P).   
To determine whether this expansion of Nkx2.1 lung progenitors represents a 
reprogramming of foregut endoderm or an increase in Nkx2.1 expression in esophagus 
and stomach endoderm, p63 immunohistochemistry was performed on E11.5 wild-type 
and Ctnnb1
(ex3)flox
:Shh-cre mutants. These data show that p63 expression is lost in the 
esophagus and proximal stomach of Ctnnb1
(ex3)flox
:Shh-cre mutants (Figure 3.9R, T). 
Moreover, co-immunostaining for p63 and Nkx2.1 on Ctnnb1
(ex3)flox
:Shh-cre mutant 
foregut sections demonstrates the lack of co-expression of Nkx2.1 and p63 in esophageal 
endoderm cells (Figure 3.9V), suggesting that activation of Wnt/!-catenin signaling 
reprograms esophagus and stomach endoderm to a lung endoderm progenitor fate. 
Altogether, these data indicate that activation of Wnt/!-catenin signaling reprograms 
posterior regions of the foregut endoderm to a lung endoderm progenitor fate, suggesting 
that activation of this pathway drives lung endoderm specification in a dominant manner.   
In conclusion, this work describes a model of Wnt2/!-catenin dependent activity 
as the required signal for specification of lung endoderm progenitors within the foregut 
(Figure 3.10). Loss of Wnt2/2b expression, or !-catenin signaling, disrupts lung 
progenitor specification leading to lung agenesis in the mouse. Conversely, dominant 
activation of !-catenin signaling promotes the expansion of lung progenitor specification 
outside of the normal foregut endoderm domain. 
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Discussion 
Mutations in several genes have resulted in either a severe truncation in lung 
development (i.e. Fgf10
-/- 
null mutants), or defects in the splanchnic mesoderm leading to 
severe foregut agenesis including the lung and esophagus (i.e. Gli2/Gli3 double mutants) 
70, 72
. In this chapter, I show that Wnt2/2b are distinct in their ability to specify lung 
progenitors within the developing foregut, whereas they are expendable in the 
specification of other organs including the thyroid, esophagus, liver, and pancreas. 
Furthermore, I show that activation of canonical Wnt signaling can reprogram esophagus 
and stomach endoderm to a lung progenitor fate. These data support the importance of 
mesoderm to endoderm signaling that promotes development of foregut derived tissues, 
and extends these findings to provide a molecular hierarchy of foregut endoderm 
specification.   
Previous reports have elucidated additional roles for Wnt signaling in the 
developing lung. Loss of !-catenin or expression of the Wnt inhibitor dikkopf1 (Dkk1) in 
lung epithelium after lung specification leads to decreased distal airway epithelial 
development and an overall proximalization of the lung 
191, 192
.  A Dermo1-cre 
mesenchymal specific loss of !-catenin in the lung leads to defective lung mesenchymal 
proliferation and development 
117, 207
. A previous report on a different Wnt2 allele did not 
report a lung phenotype although approximately 50% of null animals died by birth. This 
could be explained by the presence of significant levels of a truncated Wnt2 mRNA 
species observed in this previous allele 
141
.   
Expression of several other Wnt ligands besides Wnt2 and Wnt2b has been 
reported in the lung including Wnt7b and Wnt5a 
97, 197
. Wnt7b has been shown to 
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regulate mesenchymal proliferation as well as epithelial proliferation and maturation 
134, 
139
. Wnt5a is expressed initially in both the mesenchyme and distal epithelium of the 
developing lung, and loss of Wnt5a leads to increased mesenchymal proliferation and a 
loss in late airway maturation 
97
. Since Wnt5a has been reported to act in the non-
canonical Wnt pathway 
208
, which can antagonize !-catenin dependent canonical 
signaling, the increased proliferation observed in the lung mesenchyme of Wnt5a mutants 
could be due to increased canonical Wnt signaling in this tissue. The present study shows 
that in addition to regulation of lung development and growth, Wnt signaling through 
Wnt2/2b is essential for specification of lung endoderm progenitors in the foregut.   
In contrast to previous studies in zebrafish which demonstrated an important role 
for wnt2b in liver development and specification as well as fin development, these data 
show that Wnt2/2b are not required for mammalian liver specification 
48, 209
. The studies 
described here suggest that the role for Wnt/!-catenin signaling along the anterior-
posterior axis of the foregut varies between species, which may have occurred as 
Wnt2/2b and the canonical Wnt pathway were co-opted during evolution to specify the 
lung during the vertebrate expansion into the terrestrial environment. The specificity for 
Wnt signaling, in particular Wnt2 and Wnt2b, in regulating specification of the lung is 
interesting in light of previous reports showing an important role for this pathway in 
pancreas and liver development 
193-196
. This may be due to the precise expression pattern 
of these two Wnt ligands or to an important sensitivity of lung endoderm progenitors to 
canonical Wnt signaling. Moreover, the phenotype in Ctnnb1
(ex3)flox
:Shh-cre mutants is 
likely due to the timing and specificity of the Shh-cre line since we do not observe early 
activity in the liver (Figure 3.7O).   
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It is also important to note that since Fgf10 is a direct target of Wnt/!-catenin 
signaling 
189
, the ability of Wnt2/2b to regulate its expression in the mesoderm 
surrounding the anterior foregut in a cell autonomous manner could affect other pathways 
important for mesoderm-endoderm signaling during lung development.  Given the critical 
importance of Wnt2/2b signaling in lung endoderm specification, it will be interesting in 
future studies to determine whether simple activation of Wnt signaling can rescue the 
Wnt2/2b phenotype in foregut endoderm. Previous reports have shown that Wnt/!-
catenin signaling is also important in adult lung progenitor expansion after injury 
164, 210
. 
Thus, Wnt signaling plays a key role in embryonic as well as adult lung endoderm 
progenitor development, which reinforces the importance of understanding critical 
developmental pathways that are recapitulated upon injury and repair.   
Wnt/!-catenin signaling is a critical developmental pathway considered to be 
important for both self-renewal and differentiation of stem/progenitor cells. With 
vigorous efforts underway to determine whether agonists or antagonists can be used to 
manipulate this pathway for therapeutic purposes, our findings that Wnt signaling is 
central to lung endoderm specification and has the ability to reprogram foregut endoderm 
to a lung endoderm fate provides important information for investigating lung 
regeneration.  In summary, these data provide a molecular hierarchy of foregut endoderm 
progenitor specification with Wnt2/2b signaling acting dominantly to specify lung 
endoderm progenitors in the anterior foregut.   
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Materials and Methods 
Mice 
 The generation of the Wnt2 mutant mice was described in Chapter 2. Wnt2b 
mutant mice were generated using recombineering techniques to insert loxP sites flanking 
exons 2 and 3. Successfully targeted ES cells were used to generate chimeric mice that 
were bred to transmit these mutant alleles through the germline. Wnt2b mutants were 
crossed to CMV-cre mice to delete exons 2 and 3 and generate a null allele. The Wnt2b 
locus still carries the neomycin selection gene cDNA from the original targeted ES cell. 
Both lines were maintained on a C57BL/6:129SVJ mixed background. The generation 
and genotyping of Shh-cre, Ctnnb1
flox/flox
, BAT-GAL, and Ctnnb1
ex3flox
 mice have been 
previously described
113, 203, 205, 206
. The University of Pennsylvania Institutional Animal 
Care and Use Committee approved all animal protocols. Genotyping primer sequences 
are as follows: 
Wnt2b
neo
: 
Wnt2bForward (5’ AGCTCTTTGTCGGTGGAGGTAAAGG 3’) 
Wnt2bReverse (5’CGGCTGATGGGTAGAACCATTACCT 3’) 
Wnt2bNeoReverse (5’ATCAGCAGCCTCTGTTCCACATAC 3’) 
Histology  
Embryos were fixed in 4% paraformaldehyde for 24 hours, dehydrated in a series of 
ethanol washes, and then embedded in paraffin for tissue sectioning. Dissected 
embryonic lung buds and foreguts were fixed in 4% paraformaldehyde overnight, 
dehydrated in a series of methanol washes, and blocked in a 10% normal goat serum/PBS 
solution before whole mount immunostaining. In situ hybridization and 
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immunohistochemistry was performed as previously described
190
. Tissue sections were 
stained with the following antibodies and dilutions: anti-!-catenin (BD Transduction, 
1:100), anti-E Cadherin (Sigma, 1:50), anti-Ki67 (Vector Laboratories, 1:50), anti-
Nkx2.1 (Santa Cruz, 1:50), anti-p63 (Santa Cruz, 1:50). Quantification of positive cell 
populations was performed using at least three different tissue sections from at least three 
different embryos of the same genotype. LacZ histochemical staining of embryos was 
performed as previously described
134
. TUNEL staining was performed as previously 
described
211
. 
Quantitative RT-PCR  
Total RNA was isolated from lung tissue at the indicated time points using Trizol 
reagent, reverse transcribed using SuperScript First Strand Synthesis System (Invitrogen), 
and used in quantitative real time PCR analysis using the oligonucleotides listed below.  
Gli2 
F (5’ CGGAAGGTTGAAGGCATTGA 3’) 
R (5’ GTTTCCACATGCCATTTCTTATCTG 3’) 
Gli3 
F (5’ CCACTGTCAGATCATAGCTTCGA 3’) 
R (5’ CTTGCCGATAAGTGCCCATAG 3’) 
Nkx2.1 
F (5’ CTTCATCTTTCCCCCCTTCCT 3’) 
R (5’ GGTTGAATTTGCTTGGCTGTTT 3’) 
Wnt7b 
F (5’ GGATGCCCGTGAGATCAAAA 3’) 
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R (5’ CACACCGTGACACTTACATTCCA 3’) 
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Figure 3.1: Expression pattern of Wnt2b during lung development. 
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Figure 3.1: Expression pattern of Wnt2b during lung development. 
(A-D) In situ hybridization for Wnt2b expression on wild-type embryo cross-sections. (A, 
B) Wnt2b is expressed in the splanchnic mesoderm flanking the ventral domain of the 
mouse foregut endoderm from E9.0-E9.5. (C, D) From E12.5-E14.5, Wnt2b expression is 
observed in the mesothelium encasing the lung and at lower levels in the distal 
mesenchyme. After E14.5, Wnt2b expression is downregulated. Both Wnt2 and Wnt2b 
exhibit overlapping spatiotemporal patterns of expression (see Figure 2.1 for Wnt2 
expression pattern). Scale bars=200 µm (A, B), 600 µm (C, D). 
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Figure 3.2: Wnt2b gene targeting strategy. 
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Figure 3.2: Wnt2b gene targeting strategy. 
(A) Schematic of the Wnt2b gene targeting strategy with a representative Southern blot 
using the indicated probe and an Xba1 digest (B). A conditional knockout of the Wnt2b 
gene was generated by homologous recombination to insert loxP sites flanking exons 2 
and 3. Wnt2b mutant alleles (Wnt2b#
/#) were generated by mating the Wnt2b conditional 
mutants to transgenic mice expressing a tissue-wide cre recombinase under a minimal 
promoter (CMV-cre).  
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Figure 3.3: Loss of both Wnt2 and Wnt2b results in lung agenesis. 
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Figure 3.3: Loss of both Wnt2 and Wnt2b results in lung agenesis. 
H+E staining of histological cross-sections from E14.5 wild-type (A-C, G, J-M) and 
Wnt2/2b double knockout (DKO) mutant embryos (D-F, H, I, N-Q). (D-F) Wnt2/2b DKO 
mutants exhibit lung agenesis, however, specification of other foregut-derived organs is 
not affected in Wnt2/2b DKO mutants (H, I). As with wild-type histological cross-
sections E14.5 (G), Wnt2/2b DKO mutants develop a stomach (St), liver (Li), pancreas 
(Pa), kidney (Ki), and intestine (Gt) (H and I).  Higher magnification pictures show 
relatively normal architecture of these and other gut-derived organs in both wild-type (J-
M) and Wnt2/2b DKO mutants (N-Q).  Scale bars=800 µm (A-I), 400 µm (J-Q). 
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Figure 3.4: Loss of Wnt2 and Wnt2b leads to tracheoesophageal defects and loss of  
 
tracheal budding. 
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Figure 3.4: Loss of Wnt2 and Wnt2b leads to tracheoesophageal defects and loss of 
tracheal budding. 
H+E staining of histological cross-sections from E11.5 wild-type (A-C) and Wnt2/2b 
DKO mutant embryos (D-F). Posterior to the laryngotracheal groove (pictured in A and 
D), Wnt2/2b DKO mutants do not exhibit septation of the trachea and esophagus (E, F).  
In contrast, a clear separation of the esophagus (B and C, arrow) from the trachea (B and 
C, arrowhead) is observed in wild-type embryos. (G, H) E-cadherin whole mount 
immunostaining of endoderm dissected from wild-type (G) and Wnt2/2b DKO (H) shows 
lack of tracheal budding from the foregut in Wnt2/2b DKO mutants (G and H, arrows and 
brackets). Scale bars=200 µm (A-F). 
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Figure 3.5: Loss of Wnt2 and Wnt2b results in the loss of lung progenitor  
 
specification. 
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Figure 3.5: Loss of Wnt2 and Wnt2b results in the loss of lung progenitor 
specification. 
Histological cross-sections of E9.5 wild-type (A-C) and Wnt2/2b DKO mutant embryos 
(E-G). (A, E) At E9.5, when the lung is initially specified, there is no detectable budding 
of the trachea from the anterior foregut in Wnt2/2b DKO mutants. (B, C, F, G) 
Immunostaining for Nkx2.1 shows that wild-type embryos express Nkx2.1 in the region 
where the trachea will bud from the foregut (B), however expression is not observed in 
Wnt2/2b DKO mutants (F, outline). Nkx2.1 expression is observed in both wild-type (C) 
and Wnt2/2b DKO mutants (G) in the thyroid primordium. Immunostaining for the 
esophagus epithelial marker p63 on E11.5 wild-type (D) and Wnt2/2b DKO mutant 
embryos (H) demonstrates expression in the single gut tube in Wnt2/2b DKO mutants at 
E11.5 (D and H, arrows). Serial cross-sections through E9.5 wild-type (I-L) and Wnt2/2b 
DKO mutant embryos (M-P) confirm lack of Nkx2.1 expression in the foregut endoderm 
of Wnt2/2b DKO mutants.  Panels K and O correspond to panels B and F, respectively.  
Scale bars=100 µm (A-H), 250 µm (I-P). 
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Figure 3.6: Cell proliferation, apoptosis, and lung gene expression in Wnt2/2b DKO  
 
mutant foreguts. 
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Figure 3.6: Cell proliferation, apoptosis, and lung gene expression in Wnt2/2b DKO 
mutant foreguts. 
Histological cross-sections of E9.5 wild-type (A, D) and Wnt2/2b DKO mutant embryos 
(B, E). (A-C) Proliferation as measured by Ki-67 immunostaining is unchanged in the 
foregut endoderm of E9.5 Wnt2/2b DKO mutants (outlined region). (D, E) TUNEL 
staining does not indicate an increase in apoptotic cells in Wnt2/2b DKO mutant foreguts 
(outlined region). (F) Quantitative PCR performed on dissected foreguts of Wnt2/2b 
double heterozygous (DHET) and Wnt2/2b DKO mutants for Nkx2.1, Wnt7b, Gli2, and 
Gli3 expression.  Wnt2/2b double heterozygous mutants were used as controls since they 
were the only non-DKO controls obtained in all three litters used to generate this tissue. 
(G-N) In situ hybridization on wild-type and Wnt2/2b DKO mutant embryo cross-
sections at the denoted embryonic timepoints. (G, H) Foxa2 expression is unchanged in 
Wnt2/2b DKO mutant embryos. (I, J) Wnt7b expression, which marks early lung 
endoderm progenitors in the ventral aspect of the foregut (arrow) versus the dorsal aspect 
(dashed arrow), is lost in E10.0 Wnt2/2b DKO foregut endoderm. (K, L) Fgf10 
expression is reduced in the ventral mesoderm surrounding the foregut in Wnt2/2b DKO 
mutants. (M, N) Gli3 expression is unchanged in Wnt2/2b DKO mutants. Error bars 
indicate one standard deviation. Scale bars=200 µm (A, B, D, E, G, H, K, L), 100 µm (I, 
J, M, N). 
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Figure 3.7: Wnt2/2b signal through the !-catenin-dependent canonical pathway in  
 
the primitive lung endoderm. 
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Figure 3.7: Wnt2/2b signal through the !-catenin-dependent canonical pathway in 
the primitive lung endoderm. 
(A, B) Whole mount lacZ staining of Wnt2
-/-
:BAT-GAL embryos shows a decrease in 
canonical Wnt signaling in the anterior foregut at E10.5 (A and B, arrows).  (C-F) 
Histological cross-sections of lacZ-stained wild-type BAT-GAL, Wnt2
-/-
:BAT-GAL, 
Wnt2b
-/-
:BAT-GAL, and Wnt2/2b:BAT-GAL DKO mutant embryos show a loss of lacZ 
expression in the ventral aspect of the foregut endoderm in the region where the trachea 
is specified (brackets). (G-O) Lineage tracing of the Shh-cre line. Shh-cre:R26R embryos 
were stained at E8.75 (G) and E9.25 (H) to show cre recombinase activity in the anterior 
foregut (arrows).  (I-K) Cross-sections of E9.25 Shh-cre:R26R embryos shows lacZ 
expression in the thyroid primordium (TP, floor plate (FP), notochord (NC), and the 
ventral aspect of the foregut endoderm. (L-O) Cross-sections of an E11.5 Shh-cre:R26R 
embryo shows lacZ expression in the thyroid primordium (TP), pharyngeal endoderm 
(PE), esophagus (eso), trachea (tra), endoderm of the lung buds (lb), and the endoderm of 
the stomach (sto) and hindgut (gut). LacZ expression is absent in the early liver (li) (O). 
D=dorsal, V=ventral. Scale bars=100 µm (C-F, I-N), 200 µm (O). 
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Figure 3.8: Wnt2/2b signal through !-catenin-dependent pathways to specify lung  
 
progenitors in the foregut endoderm. 
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Figure 3.8: Wnt2/2b signal through !-catenin-dependent pathways to specify lung 
progenitors in the foregut endoderm. 
(A-H) Histological cross-sections from E10.5 wild-type (A-D) and Ctnnb1
flox/flox
:Shh-cre 
mutant embryos (E-H). H+E stained cross-sections show that genetic deletion of foregut 
endoderm !-catenin expression leads to tracheoesophageal defects and absence of lung 
development in Ctnnb1
flox/flox
:Shh-cre mutants (E-G).  (D, H) Nkx2.1 immunostaining 
demonstrates expression in the ventral foregut endoderm of wild-type embryos (D), but 
Nkx2.1 expression is lost in Ctnnb1
flox/flox
:Shh-cre mutants (H), indicating a loss of lung 
specification in these mutants. (I, J) Immunostaining for !-catenin expression in 
Ctnnb1
flox/flox
:Shh-cre mutants at E9.5 shows reduced expression of !-catenin in the 
ventral portion (V) of the anterior foregut (J), confirming !-catenin gene excision. (K, L) 
p63 immunostaining shows that the foregut tube in Ctnnb1
flox/flox
:Shh-cre mutants (L) 
retains esophagus identity at E9.5. (M, N) Nkx2.1 immunostaining at E9.5 shows that 
thyroid (TP) specification is retained in Ctnnb1
flox/flox
:Shh-cre mutants (N) in tissue 
anterior to the presumptive site of the tracheal bifurcation. (O, P) E-cadherin whole 
mount immunostaining shows normal tracheal budding in wild-type embryos (O, arrow) 
and lack of tracheal budding in Ctnnb1
flox/flox
:Shh-cre mutants (P, arrow).  The esophagus 
is still present in the Ctnnb1
flox/flox
:Shh-cre mutants (P’, bracket). D=dorsal, 
Es=esophagus, Tr=trachea, TP=thyroid primordium, V=ventral.  Scale bars=200 µm (A-
H), 100 µm (I-K), 50 µm (M, N).  
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Figure 3.9: Activation of Wnt/!-catenin signaling leads to expansion of lung  
 
endoderm progenitors into the stomach. 
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Figure 3.9: Activation of Wnt/!-catenin signaling leads to expansion of lung 
endoderm progenitors into the stomach. 
Histological cross-sections of E10.5 wild-type (A-D) and Ctnnb1
(ex3)flox
:Shh-cre mutant 
embryos (E-H). H+E stained cross-sections show that trachea-esophagus septation is 
disrupted in Ctnnb1
(ex3)flox
:Shh-cre mutants (F, arrowheads). (D, H) Immunostaining for 
Nkx2.1 expression reveals expansion of Nkx2.1 positive lung endoderm progenitors into 
the stomach (St, outlined region). (I-N) H+E stained cross-sections from E11.5 wild-type 
(I and J) and Ctnnb1
(ex3)flox
:Shh-cre (M and N) mutant embryos. (K-P) Immunostaining 
for Nkx2.1 expression shows expression of Nkx2.1 in the esophagus of E11.5 
Ctnnb1
(ex3)flox
:Shh-cre mutants (O, arrow), but not in wild-type embryos (K, arrow).  
Expression of Nkx2.1 is also extended into the stomach of E11.5 Ctnnb1
(ex3)flox
:Shh-cre 
mutants (P, arrows). (Q-T) Immunostaining for p63 expression shows reduced expression 
in the esophagus and stomach endoderm of E11.5 Ctnnb1
(ex3)flox
:Shh-cre mutants (R, T).  
(U-V) Co-immunostaining for both Nkx2.1 and p63 expression shows that p63-positive 
endoderm is lost (V’) while Nkx2.1-positive endoderm is present in the esophagus (V, 
arrow). E=esophagus, Lb=lung bud, St=stomach.  Scale bar=200 µm (A-I, M, K, O, Q, R, 
U-V), 400 µm (J, N, L, P), 30 µm (S, T). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
118 
Figure 3.10: Model of Wnt2/Wnt2b and !-catenin signaling for lung progenitor  
 
specification in the foregut endoderm. 
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Figure 3.10: Model of Wnt2/Wnt2b and !-catenin signaling for lung progenitor 
specification in the foregut endoderm. 
Model showing necessity and sufficiency of Wnt2/2b and !-catenin signaling for lung 
progenitor specification in the anterior foregut endoderm. Wnt2 and Wnt2b expression in 
the splanchnic mesoderm signals in a paracrine manner to the adjacent foregut endoderm 
activating !-catenin signaling to specify lung endoderm progenitors. Loss of either 
Wnt2/Wnt2b expression in the mesoderm, or !-catenin signaling in the foregut 
endoderm, leads to the loss of lung endoderm progenitors and lung agenesis. Moreover, 
dominant activation of !-catenin signaling in the endoderm leads to the expansion of lung 
progenitors into the presumptive stomach. 
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Chapter 4: Conclusions and Future Directions 
 
Summary 
Lung development is a complex process involving input from multiple signaling 
pathways to coordinate specification, morphogenetic, and differentiation events. The Wnt 
signaling pathway indisputably plays a critical role in lung development, given the 
reported lung defects in several Wnt knockout and !-catenin conditional mutant mouse 
models. However, the contributions of individual Wnt ligands and canonical Wnt/!-
catenin signaling to the specification and development of respiratory cell types have not 
been fully addressed. Wnt ligands are secreted molecules that can activate downstream 
signaling pathways in cell-autonomous and non-cell autonomous manners. An important 
theme in the development of organs is the necessity for cross-talk between different 
tissue types, such as the developing lung mesenchyme and endoderm. Wnts as 
intercellular ligands can act upon multiple tissues, thereby adding complexity to their 
functions during the development of organs. The two roles identified for Wnt2 signaling 
in this thesis reflect the dual autocrine and paracrine signaling capabilities of Wnt 
ligands.  
In this dissertation, I analyze a series of mouse models to determine the function 
of Wnt2 signaling in lung development. These studies reveal two distinct roles for Wnt2 
signaling during lung development: one in the splanchnic mesoderm flanking the site of 
lung specification in the foregut endoderm, and a second role in the developing lung 
mesenchyme.  
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In Chapter 2, I describe a role for Wnt2 signaling in the development of the lung 
mesenchyme. I show that Wnt2 signaling is required for overall lung growth and 
development of airway smooth muscle. Additionally, I place Wnt2 signaling as an 
upstream regulator in a hierarchy of smooth muscle development. I show that Wnt2 
signaling promotes the activation of an early smooth muscle transcriptional regulatory 
network that supports the development of immature smooth muscle. I also show that 
Wnt2 signaling activates downstream FGF-10 signaling, a pathway well known to 
promote the development of airway smooth muscle.  
In Chapter 3, I elaborate my investigations into the functions of Wnt2 signaling 
by studying the cooperativity between Wnt2 and its associated family member-Wnt2b, 
which is co-expressed with Wnt2 in the lung. My studies reveal that both ligands signal 
cooperatively in the splanchnic mesoderm tissue prior to lung morphogenesis to regulate 
the specification of lung progenitors in the foregut endoderm. The combined loss of 
Wnt2/2b function results in the complete loss of the lung, and this loss is tightly restricted 
to the lung field in the foregut. I also demonstrate that Wnt2 and Wnt2b mediate their 
effects on the endoderm via activation of !-catenin signaling in the foregut, and that an 
endoderm-specific loss of !-catenin recapitulates the lung agenesis phenotype. 
In contrast to previous reports, these results demonstrate that Wnt2 signaling is 
critical for lung development. The data collected from these investigations establishes a 
firm understanding of what processes Wnt2 and Wnt2b coordinate during embryonic 
development. The data also prompts additional questions concerning the roles of Wnt2 
and !-catenin signaling in both the embryonic and adult lung. 
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Future Directions 
 
What cell lineages are Wnt2-expressing cells contributing to during lung 
development? 
 The data presented in Chapter 2 on the Wnt2 loss-of-function model suggest that 
Wnt2 signaling is having a critical impact on the development of smooth muscle in the 
lung. However, this result does not definitely establish whether Wnt2-expressing cells are 
giving rise to smooth muscle lineages only, or to other mesenchymal lineages in the 
mouse lung.  
To better understand the lineage contributions of Wnt2-expressing cells, our 
laboratory has recently generated a tamoxifen-inducible knock-in Wnt2
cre/ERT2
 allele 
(Figure 4.1). This allele carries a tamoxifen-inducible cre recombinase cDNA cassette 
homologously inserted at the Wnt2 locus. This allele will permit conditional fatemapping 
of Wnt2-expressing cells during lung development based on the endogenous activity of 
the Wnt2 promoter. An initial experiment testing for cre recombinase activity using the 
Rosa26 reporter mouse strain indicates that the allele is activated in lung tissue; however, 
the efficiency of cre recombinase-mediated excision is still unclear and the tamoxifen 
induction method is being optimized. Use of this genetic tool will enable us to more 
thoroughly study and define the contribution and behavior of Wnt2-expressing cells in the 
lung.  
It will be very interesting to see whether fatemapping in the Wnt2
cre/ERT2
 mouse 
model demonstrates that Wnt2-expressing cells contribute to smooth muscle in the lung. 
Additionally, it will also be of interest to see whether Wnt2-expressing cells contribute to 
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both vascular and smooth muscle cells. Wnt2 signaling is reported to mediate endothelial 
gene expression in embryoid bodies
142
, and there are subtle molecular deficiencies during 
early endothelial development in Wnt2
-/-
 null mutant lungs (see Chapter 2). Therefore it is 
possible that subpopulations of Wnt2-expressing cells contribute to the developing 
endothelium, and this will be revealed through fatemapping. The fatemapping studies 
may also reveal additional lineage contributions of Wnt2-expressing cells in the 
mesenchyme. Finally, fatemapping in the Wnt2
cre/ERT2 
model may also serve as an 
additional tool to study the behaviors of Wnt2-expressing cells (e.g. migration, EMT) in 
the context of reduced Wnt2 signaling, other genetic deficiencies, or during lung injury 
and repair. 
The reported Wnt2 expression data indicates that Wnt2 is expressed in the 
developing lung mesenchyme
141, 143, 159
. However the expression data is based on in situ 
hybridization experiments, and does not exclude the possibility that Wnt2 is expressed at 
low levels in the developing lung epithelium. Preliminary data indicate that Wnt2 is 
expressed at low levels in the postnatal airway epithelium (discussed below), and is 
highly upregulated after airway injury (Figure 4.2). The expression of Wnt2 in the adult 
epithelium suggests the possibility for the presence of Wnt2-expressing cells in the 
developing epithelium. Thus, the Wnt2
cre/ERT2 
model may reveal a previously unknown 
site of Wnt2 expression in the embryonic lung. 
A role for Wnt2 signaling in asthma? 
Recent studies show upregulation of Wnt/!-catenin signaling in airway smooth 
muscle in a mouse model of allergen-induced asthma
22, 212
. Given the prominent role 
described in Chapter 2 for Wnt2 signaling in airway smooth muscle development, it will 
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be interesting to look at whether Wnt2 expression is activated in airway smooth muscle in 
an asthmatic model. To investigate further and genetically determine whether Wnt2 
signaling is activated during asthma, the Wnt2
cre/ERT2
 fatemapping model could be utilized 
in the induced asthma model and analyzed for Wnt2 signaling activity. Additionally, the 
contribution of Wnt2-expressing cells to the asthmatic phenotype can be analyzed, 
including airway smooth muscle proliferation.  
Is Wnt2 mediating its effects via cross-talk with the adjacent epithelium? 
 Epithelial-mesenchymal interactions are integral to the development of many cells 
types in the lung. Studies have shown that disruption of Wnt7b signaling leads to defects 
in smooth muscle development in the lung mesenchyme
134
. Expression of Wnt7b is 
downregulated in Wnt2
-/-
 null mutant lungs, suggesting a possible paracrine mechanism 
for Wnt2 signaling to the adjacent epithelium to activate Wnt7b expression and 
coordinate smooth muscle development. Interestingly, the expression of other key 
signaling factors known to regulate smooth muscle development are unaltered, and 
therefore the relative contribution of reduced epithelial-mesenchymal signaling to the loss 
of smooth muscle in Wnt2
-/-
 null mutant lungs is uncertain.  
To interrogate the contribution of epithelial signaling in Wnt2
-/-
 null mutant lungs, 
it will be interesting to isolate Wnt2
-/-
 null mutant lung mesenchyme and try rescuing the 
loss of smooth muscle gene expression with rWnt2 treatment. If Wnt2 is signaling in an 
autocrine manner to regulate smooth muscle development, then rWnt2 should fully 
rescue gene expression. If however, Wnt2 signaling requires the presence of the 
epithelium to mediate smooth muscle development, the rescue effect may be mild or 
negligible in the presence of rWnt2. An alternative approach to examine the requirements 
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for epithelial cross-talk would be to culture isolated wildtype lung mesenchyme in the 
presence of rWnt2, and examine whether smooth muscle gene expression is significantly 
upregulated. If Wnt2-mediated epithelial cross-talk is required for coordinating smooth 
muscle gene expression, I would not predict a dramatic upregulation of gene expression 
in the presence of rWnt2. 
Can ectopic Wnt2 expression impose a lung progenitor identity on early endoderm? 
 An intriguing concept emerging from the results in Chapter 3 is that of Wnt2 
signaling serving as a master regulator of the lung progenitor fate by activating !-catenin 
signaling in the foregut endoderm. A question left unresolved from the investigations 
described in Chapter 3 is whether the restricted effects of lung progenitor loss in the 
Wnt2 signaling loss-of-function model is due to the restricted expression pattern of 
Wnt2/2b, the presence of other factors expressed along the A-P axis in the mesoderm 
flanking the endoderm, or intrinsic patterning in the foregut endoderm which limits the 
responsiveness to Wnt2/2b signaling. 
It will be interesting to test whether ectopic Wnt2 signaling can expand lung 
progenitor identity in isolated endoderm, using published techniques
50
. If rWnt2 can 
induce Nkx2.1 expression along the endoderm tract beyond the zone of the foregut, this 
would suggest that the early endoderm is competent to give rise to Nkx2.1-positive 
progenitors. If rWnt2 is not capable of promoting Nkx2.1 identity beyond the foregut 
region, this would suggest that intrinsic factors expressed in the endoderm are already 
acting to restrict the foregut competence. Additionally, if the endoderm is cultured with 
adjacent mesoderm and rWnt2 is still able to expand the Nkx2.1 expression domain, this 
would suggest that the restricted pattern of Nkx2.1 expression in wild-type embryos is a 
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consequence of the restricted Wnt2/2b expression pattern. If, however, rWnt2 is unable to 
expand Nkx2.1 expression in the presence of mesoderm, this would suggest that other 
factors expressed in the mesoderm are restricting the activity of Wnt2 signaling. 
A role for Wnt2/!-catenin signaling in lung stem cells? 
In Chapter 3, I demonstrated that Wnt2 and !-catenin signaling coordinate the 
specification of an Nkx2.1-positive lung progenitor cell population in the embryo. This 
raises the question of whether or not a similar mechanism imposes a respiratory 
progenitor fate in embryonic stem cells (ESCs) and cells of the adult lung. A significant 
barrier to the use of stem cell-derived therapies is the lack of knowledge on how to 
efficiently direct a pluripotent cell type towards a homogenous population of tissue-
specific progenitors. Moreover, successful attempts too often rely on the introduction of 
transgenes to use tissue-specific promoters to drive differentiation
213, 214
. There are 
established methods for culturing mouse ESCs into definitive endoderm
215, 216
, and it will 
be interesting to test whether adding rWnt2 to ESC-derived endoderm would promote the 
specification of Nkx2.1-expressing progenitors. Additionally, it will also be interesting to 
test whether activating !-catenin signaling using the !-catenin agonist lithium chloride 
would also promote Nkx2.1 expression.  
One caveat to this approach is that it will require careful characterization of 
Nkx2.1 cells to distinguish between thyroid and lung progenitors. Sustained Wnt/!-
catenin signaling will also block differentiation in lung cell types
114, 217
, therefore 
persistent exposure to rWnt2 and activated !-catenin signaling may inhibit the 
differentiation of Nkx2.1-postive cells into mature respiratory lineages. 
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Is Wnt2 signaling important for mediating the lung injury and repair response?   
An emerging paradigm in adult injury/repair and disease mechanisms is the re-
expression of critical developmental signaling pathways
218-220
. Wnt ligands are not 
expressed at high levels in adult tissues; therefore the role for Wnt signaling in adult 
tissues is relatively unknown. This prompts the question of whether Wnt2 signaling is 
activated in adult airways during injury and repair processes.  
Preliminary data indicate that Wnt2 may play a role in the adult lung during 
airway repair. In the post-natal mouse lung, Wnt2 is expressed at low levels (Figure 4.2A-
C). However, after naphthalene-induced bronchiolar airway injury, Wnt2 expression is 
highly upregulated in both the epithelium and mesenchyme (Figure 4.2D-F). The 
expression of Wnt2 in the injured epithelium is intriguing, and could be originating in 
cells undergoing EMT in the basal lamina of the denuded airway or de novo Wnt2 
expression in the exfoliating airway epithelium. Possible insights into the functions of 
Wnt2 re-expression during airway injury will be accomplished by examining the repair 
response in surviving Wnt2
-/- 
null mutants (less than 20% survive after birth) or by 
examining the response in Wnt2/2b heterozygous compound mutants.  The injury and 
repair response will be examined at the cellular level by immunohistochemistry assessing 
for proliferation or differentiation of repopulating airway cell types in the denuded 
airways.  
If Wnt2-deficient adult lungs lose the ability to repair properly, it would be 
interesting to test whether a simple injection of lithium chloride would rescue repair by 
activating !-catenin signaling. Additionally, our laboratory has its own hyperoxic 
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chamber, which will permit testing for Wnt2 re-expression in other types of more distal 
airway injury. 
 
Concluding remarks 
 In this dissertation I have investigated the function of Wnt2 and Wnt/!-catenin 
signaling during lung development. These investigations describe the roles of Wnt2 and 
Wnt/!-catenin signaling in lung specification within the mouse foregut endoderm, and in 
the development of airway smooth muscle. Overall, these results contribute significantly 
to the body of knowledge for Wnt signaling in lung development. In examining these 
data in conjunction with the published literature, two important themes stand out. First, 
the activities, interactions with other pathways, and functions of Wnt signaling in the 
lung are dynamic. The requirements for Wnt signaling activity appear to occur at discrete 
timepoints during lung morphogenesis, and in or between discrete tissue and cellular 
compartments. Secondly, an increasing amount of published data implicates Wnt 
signaling in lung airway repair and pathogenesis. Therefore, it will be exciting to see how 
these and future findings will transition into investigations on adult pathological 
processes and regenerative technologies.   
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Figure 4.1: Schematic of Wnt2
cre/ERT2
 knock-in strategy. 
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Figure 4.1: Schematic of Wnt2
cre/ERT2
 knock-in strategy. 
 
Diagram of the Wnt2
cre/ERT2
 gene targeting strategy with a representative Southern blot 
using the indicated probe/ HindIII.  A cre recombinase cDNA fused to a mutant form of 
the human estrogen receptor ligand binding domain (creERT2) was used to replace the 
coding region of exon 1 of Wnt2.  The mutant receptor binds only the synthetic ligand 4-
hydroxytamoxifen, and in the presence of ligand cre recombinase is expressed in all cells 
that express the endogenous gene. The neomycin cassette was removed using Flper mice 
(flp sites=green circles).  
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Figure 4.2: Upregulation of Wnt2 expression after airway injury. 
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Figure 4.2: Upregulation of Wnt2 expression after airway injury. 
Histological cross-sections showing in situ hybridizations for Wnt2 expression in the 
postnatal wild-type mouse lung after naphthalene injury at 2, 4, and 7 days post-injection. 
(A-C) In control animals receiving saline intraperitoneal injections, low levels of Wnt2 
expression are observed in the uninjured lung. However upon intraperitoneal naphthalene 
injection, Wnt2 expression is highly upregulated throughout the airway epithelium and 
mesenchyme at 2 days (C), and Wnt2 expression levels remain upregulated through to 
day 7 of injury (E and F). Scale bars=200 µm (A-F). 
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